1
|
Rojas-Solé C, Pinilla-González V, Lillo-Moya J, González-Fernández T, Saso L, Rodrigo R. Integrated approach to reducing polypharmacy in older people: exploring the role of oxidative stress and antioxidant potential therapy. Redox Rep 2024; 29:2289740. [PMID: 38108325 PMCID: PMC10732214 DOI: 10.1080/13510002.2023.2289740] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/19/2023] Open
Abstract
Increased life expectancy, attributed to improved access to healthcare and drug development, has led to an increase in multimorbidity, a key contributor to polypharmacy. Polypharmacy is characterised by its association with a variety of adverse events in the older persons. The mechanisms involved in the development of age-related chronic diseases are largely unknown; however, altered redox homeostasis due to ageing is one of the main theories. In this context, the present review explores the development and interaction between different age-related diseases, mainly linked by oxidative stress. In addition, drug interactions in the treatment of various diseases are described, emphasising that the holistic management of older people and their pathologies should prevail over the individual treatment of each condition.
Collapse
Affiliation(s)
- Catalina Rojas-Solé
- Molecular and Clinical Pharmacology Program, Institute of Biomedical Sciences, Faculty of Medicine, University of Chile, Santiago, Chile
| | - Víctor Pinilla-González
- Molecular and Clinical Pharmacology Program, Institute of Biomedical Sciences, Faculty of Medicine, University of Chile, Santiago, Chile
| | - José Lillo-Moya
- Molecular and Clinical Pharmacology Program, Institute of Biomedical Sciences, Faculty of Medicine, University of Chile, Santiago, Chile
| | - Tommy González-Fernández
- Molecular and Clinical Pharmacology Program, Institute of Biomedical Sciences, Faculty of Medicine, University of Chile, Santiago, Chile
| | - Luciano Saso
- Department of Physiology and Pharmacology “Vittorio Erspamer”, Faculty of Pharmacy and Medicine, Sapienza University, Rome, Italy
| | - Ramón Rodrigo
- Molecular and Clinical Pharmacology Program, Institute of Biomedical Sciences, Faculty of Medicine, University of Chile, Santiago, Chile
| |
Collapse
|
2
|
Siprelle K, Kennedy AJ, Hill EB, Hinton A, Shi N, Madril P, Grainger E, Taylor C, Nahikian-Nelms M, Spees C, Tabung FK, Hart PA, Roberts KM. An Improved Assessment Method to Estimate (Poly)phenol Intake in Adults with Chronic Pancreatitis. Dig Dis Sci 2024:10.1007/s10620-024-08417-6. [PMID: 38850506 DOI: 10.1007/s10620-024-08417-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/06/2023] [Accepted: 03/26/2024] [Indexed: 06/10/2024]
Abstract
BACKGROUND Insights into (poly)phenol exposure represent a modifiable factor that may modulate inflammation in chronic pancreatitis (CP), yet intake is poorly characterized and methods for assessment are underdeveloped. AIMS The aims are to develop and test a method for estimating (poly)phenol intake from a 90-day food frequency questionnaire (FFQ) using the Phenol-Explorer database and determine associations with dietary patterns in CP patients versus controls via analysis of previously collected cross-sectional data. METHODS Fifty-two CP patients and 48 controls were recruited from an ambulatory clinic at a large, academic institution. To assess the feasibility of the proposed methodology for estimating dietary (poly)phenol exposure, a retrospective analysis of FFQ data was completed. Mann-Whitney U tests were used to compare (poly)phenol intake by group; Spearman correlations and multivariable-adjusted log-linear associations were used to compare (poly)phenol intakes with dietary scores within the sample. RESULTS Estimation of (poly)phenol intake from FFQs was feasible and produced estimates within a range of intake previously reported. Total (poly)phenol intake was significantly lower in CP vs controls (463 vs. 567mg/1000kcal; p = 0.041). In adjusted analyses, higher total (poly)phenol intake was associated with higher HEI-2015 (r = 0.34, p < 0.001), aMED (r = 0.22, p = 0.007), EDIH (r = 0.29, p < 0.001), and EDIP scores (r = 0.35, p < 0.001), representing higher overall diet quality and lower insulinemic and anti-inflammatory dietary potentials, respectively. CONCLUSIONS Using enhanced methods to derive total (poly)phenol intake from an FFQ is feasible. Those with CP have lower total (poly)phenol intake and less favorable dietary pattern indices, thus supporting future tailored dietary intervention studies in this population.
Collapse
Affiliation(s)
- Katharine Siprelle
- School of Health and Rehabilitation Sciences, College of Medicine, The Ohio State University, 453 W. 10th Ave, Columbus, OH, 43210, USA
- The Ohio State University Wexner Medical Center, 410 W. 10th Ave, Columbus, OH, 43210, USA
| | - Ashley J Kennedy
- School of Health and Rehabilitation Sciences, College of Medicine, The Ohio State University, 453 W. 10th Ave, Columbus, OH, 43210, USA
- Division of Medical Oncology, Department of Internal Medicine, The Ohio State University College of Medicine, 410 W. 12th Ave, Columbus, OH, 43210, USA
| | - Emily B Hill
- School of Health and Rehabilitation Sciences, College of Medicine, The Ohio State University, 453 W. 10th Ave, Columbus, OH, 43210, USA
| | - Alice Hinton
- Division of Biostatistics, College of Public Health, The Ohio State University, 1841 Neil Ave, Columbus, OH, 43210, USA
- The Ohio State University Wexner Medical Center, 410 W. 10th Ave, Columbus, OH, 43210, USA
| | - Ni Shi
- Molecular Carcinogenesis and Chemoprevention Program, The Ohio State University, Comprehensive Cancer Center, 410 W. 12th Ave, Columbus, OH, 43210, USA
- Division of Medical Oncology, Department of Internal Medicine, The Ohio State University College of Medicine, 410 W. 12th Ave, Columbus, OH, 43210, USA
| | - Peter Madril
- School of Health and Rehabilitation Sciences, College of Medicine, The Ohio State University, 453 W. 10th Ave, Columbus, OH, 43210, USA
| | - Elizabeth Grainger
- Division of Medical Oncology, Department of Internal Medicine, The Ohio State University College of Medicine, 410 W. 12th Ave, Columbus, OH, 43210, USA
| | - Christopher Taylor
- School of Health and Rehabilitation Sciences, College of Medicine, The Ohio State University, 453 W. 10th Ave, Columbus, OH, 43210, USA
| | - Marcia Nahikian-Nelms
- School of Health and Rehabilitation Sciences, College of Medicine, The Ohio State University, 453 W. 10th Ave, Columbus, OH, 43210, USA
| | - Colleen Spees
- School of Health and Rehabilitation Sciences, College of Medicine, The Ohio State University, 453 W. 10th Ave, Columbus, OH, 43210, USA
| | - Fred K Tabung
- Molecular Carcinogenesis and Chemoprevention Program, The Ohio State University, Comprehensive Cancer Center, 410 W. 12th Ave, Columbus, OH, 43210, USA
- Division of Medical Oncology, Department of Internal Medicine, The Ohio State University College of Medicine, 410 W. 12th Ave, Columbus, OH, 43210, USA
| | - Phil A Hart
- The Ohio State University Wexner Medical Center, 410 W. 10th Ave, Columbus, OH, 43210, USA
| | - Kristen M Roberts
- School of Health and Rehabilitation Sciences, College of Medicine, The Ohio State University, 453 W. 10th Ave, Columbus, OH, 43210, USA.
- The Ohio State University Wexner Medical Center, 410 W. 10th Ave, Columbus, OH, 43210, USA.
| |
Collapse
|
3
|
Biancaniello EC, Tiessen S, Hartman B, Battram DS. Dietary polyphenol intake in the Canadian population: Findings from the 2015 Canadian Community Health Survey-Nutrition. CANADIAN JOURNAL OF PUBLIC HEALTH = REVUE CANADIENNE DE SANTE PUBLIQUE 2024; 115:315-331. [PMID: 38180640 PMCID: PMC11027756 DOI: 10.17269/s41997-023-00845-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/02/2023] [Accepted: 11/28/2023] [Indexed: 01/06/2024]
Abstract
OBJECTIVES This study aimed to estimate usual polyphenol intake among Canadians using the nationally representative 2015 Canadian Community Health Survey-Nutrition and to explore the main dietary contributors to polyphenol intake and the sociodemographic and lifestyle factors that may impact polyphenol intake. METHODS Dietary information was collected from 19,409 respondents using 24-h dietary recalls. The polyphenol content of foods was estimated using the Phenol-Explorer Database (version 3.6). Daily intake values for total polyphenols (adjusted to energy intake), main classes, and subclasses were calculated for each respondent and dietary recall. Usual intake was estimated by age/sex groups and by sociodemographic and lifestyle characteristics independently for adults and children using the National Cancer Institute method. Given-day arithmetic mean polyphenol intakes and mean proportions of main classes contributing to sum total polyphenol intakes were explored. Population proportions were used to determine dietary contributors. RESULTS Usual total polyphenol intake was 1119.3 mg/1000 kcal/day (95% CI: 1090.5, 1148.1) for adults ≥ 19 years and 473.0 mg/1000 kcal/day (95% CI: 454.9, 491.0) for children 2‒18 years. Generally, total polyphenol intakes differed by age, sex, ethnicity, and household education status and were higher among coffee and tea consumers. Most polyphenols came from flavonoids (40.0%) and phenolic acids (49.8%), with children consuming more flavonoids and other polyphenols and adults more phenolic acids. The top food contributors to polyphenol intake were coffee (26.8%), tea (8.9%), fruit juice (4.2%), banana (4.1%), and apple (3.8%). CONCLUSION Usual intake of total polyphenols among Canadians differed primarily by age. Non-alcoholic beverages were top contributors to total polyphenol intake.
Collapse
Affiliation(s)
- Emma C Biancaniello
- School of Food and Nutritional Sciences, Brescia University College, London, ON, Canada.
| | - Sarah Tiessen
- School of Food and Nutritional Sciences, Brescia University College, London, ON, Canada
| | - Brenda Hartman
- School of Food and Nutritional Sciences, Brescia University College, London, ON, Canada
| | - Danielle S Battram
- School of Food and Nutritional Sciences, Brescia University College, London, ON, Canada
- Schulich Interfaculty Program in Public Health, Western University, London, ON, Canada
| |
Collapse
|
4
|
Haș IM, Teleky BE, Vodnar DC, Ștefănescu BE, Tit DM, Nițescu M. Polyphenols and Cardiometabolic Health: Knowledge and Concern among Romanian People. Nutrients 2023; 15:nu15102281. [PMID: 37242164 DOI: 10.3390/nu15102281] [Citation(s) in RCA: 4] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/27/2023] [Revised: 05/05/2023] [Accepted: 05/08/2023] [Indexed: 05/28/2023] Open
Abstract
The cardiometabolic health of the population is a crucial indicator of public health, considering the significant impact of cardiovascular disease (CVD) and diabetes on global mortality. Determining the population's knowledge and the predictors of these pathologies is essential in developing effective educational and clinical strategies for the prevention and management of cardiometabolic risk (CMR). Polyphenols are natural compounds with a multitude of beneficial effects on cardiometabolic health. This study explored the current knowledge, understanding, and awareness of CMR, the benefits of polyphenols among Romanians, and how sociodemographic and clinical characteristics influence this aspect. Five hundred forty-six subjects responded anonymously to an online questionnaire designed to assess their knowledge. The data were collected and analyzed based on gender, age, education level, and BMI status. Most respondents expressed concern to a great or very great extent about their health (78%) and food (60%), with significant differences (p < 0.05) depending on age, educational level, and BMI status. Of the respondents, 64.8% declared that they were familiar with the CMR term. Still, the results showed a weak correlation between the stated risk factors and the self-assessment of increased risk (r = 0.027) for CVD or diabetes. Only 35% of the respondents reported a good or very good knowledge of the term "polyphenols", 86% recognized the antioxidant effect, and significantly fewer (26%) recognized the prebiotic effect. Developing and implementing targeted educational strategies to enhance learning and individual behaviors related to CMR factors and the benefits of polyphenols is necessary.
Collapse
Affiliation(s)
- Ioana Mariana Haș
- Doctoral School of Biomedical Sciences, University of Oradea, 410087 Oradea, Romania
| | - Bernadette-Emőke Teleky
- Institute of Life Sciences, University of Agricultural Sciences and Veterinary Medicine, 400372 Cluj-Napoca, Romania
- Department of Food Science and Technology, University of Agricultural Sciences and Veterinary Medicine, 400372 Cluj-Napoca, Romania
| | - Dan-Cristian Vodnar
- Institute of Life Sciences, University of Agricultural Sciences and Veterinary Medicine, 400372 Cluj-Napoca, Romania
- Department of Food Science and Technology, University of Agricultural Sciences and Veterinary Medicine, 400372 Cluj-Napoca, Romania
| | - Bianca Eugenia Ștefănescu
- Institute of Life Sciences, University of Agricultural Sciences and Veterinary Medicine, 400372 Cluj-Napoca, Romania
| | - Delia Mirela Tit
- Department of Pharmacy, Faculty of Medicine and Pharmacy, University of Oradea, 29 N. Jiga St., 410028 Oradea, Romania
| | - Maria Nițescu
- Department of Preclinical-Complementary Sciences, University of Medicine and Pharmacy "Carol Davila", 050474 Bucharest, Romania
| |
Collapse
|
5
|
Barrea L, Vetrani C, Verde L, Frias-Toral E, Ceriani F, Cernea S, Docimo A, Graziadio C, Tripathy D, Savastano S, Colao A, Muscogiuri G. Comprehensive Approach to Medical Nutrition Therapy in Patients with Type 2 Diabetes Mellitus: From Diet to Bioactive Compounds. Antioxidants (Basel) 2023; 12:904. [PMID: 37107279 PMCID: PMC10135374 DOI: 10.3390/antiox12040904] [Citation(s) in RCA: 5] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/23/2022] [Revised: 03/29/2023] [Accepted: 03/30/2023] [Indexed: 04/29/2023] Open
Abstract
In the pathogenesis of type 2 diabetes mellitus (T2DM), diet plays a key role. Individualized medical nutritional therapy, as part of lifestyle optimization, is one of the cornerstones for the management of T2DM and has been shown to improve metabolic outcomes. This paper discusses major aspects of the nutritional intervention (including macro- and micronutrients, nutraceuticals, and supplements), with key practical advice. Various eating patterns, such as the Mediterranean-style, low-carbohydrate, vegetarian or plant-based diets, as well as healthy eating plans with caloric deficits have been proven to have beneficial effects for patients with T2DM. So far, the evidence does not support a specific macronutrient distribution and meal plans should be individualized. Reducing the overall carbohydrate intake and replacing high glycemic index (GI) foods with low GI foods have been shown as valid options for patients with T2DM to improve glycemic control. Additionally, evidence supports the current recommendation to reduce the intake of free sugars to less than 10% of total energy intake, since their excessive intake promotes weight gain. The quality of fats seems to be rather important and the substitution of saturated and trans fatty acids with foods rich in monounsaturated and polyunsaturated fats lowers cardiovascular risk and improves glucose metabolism. There is no benefit of supplementation with antioxidants, such as carotene, vitamins E and C, or other micronutrients, due to the lack of consistent evidence showing efficacy and long-term safety. Some studies suggest possible beneficial metabolic effects of nutraceuticals in patients with T2DM, but more evidence about their efficacy and safety is still needed.
Collapse
Affiliation(s)
- Luigi Barrea
- Dipartimento di Scienze Umanistiche, Università Telematica Pegaso, Via Porzio, Centro Isola F2, 80143 Napoli, Italy
- Centro Italiano per la Cura e il Benessere del Paziente con Obesità (C.I.B.O), Unità di Endocrinologia, Diabetologia e Andrologia, Dipartimento di Medicina Clinica e Chirurgia, Università degli Studi di Napoli Federico II, Via Sergio Pansini 5, 80131 Naples, Italy
| | - Claudia Vetrani
- Dipartimento di Scienze Umanistiche, Università Telematica Pegaso, Via Porzio, Centro Isola F2, 80143 Napoli, Italy
- Centro Italiano per la Cura e il Benessere del Paziente con Obesità (C.I.B.O), Unità di Endocrinologia, Diabetologia e Andrologia, Dipartimento di Medicina Clinica e Chirurgia, Università degli Studi di Napoli Federico II, Via Sergio Pansini 5, 80131 Naples, Italy
| | - Ludovica Verde
- Department of Public Health, University of Naples Federico II, Via Sergio Pansini 5, 80131 Naples, Italy
| | - Evelyn Frias-Toral
- School of Medicine, Universidad Católica Santiago de Guayaquil, Av. Pdte. Carlos Julio Arosemena Tola, Guayaquil 090615, Ecuador
| | - Florencia Ceriani
- Nutrition School, Universidad de la Republica (UdelaR), Montevideo 11100, Uruguay
| | - Simona Cernea
- Department M3/Internal Medicine I, George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Târgu Mures, 540146 Târgu Mureş, Romania
- Diabetes, Nutrition and Metabolic Diseases Outpatient Unit, Emergency County Clinical Hospital, 540146 Târgu Mureş, Romania
| | - Annamaria Docimo
- Unità di Endocrinologia, Diabetologia e Andrologia, Dipartimento di Medicina Clinica e Chirurgia, Università degli Studi di Napoli Federico II, Via Sergio Pansini 5, 80131 Naples, Italy
| | - Chiara Graziadio
- Centro Italiano per la Cura e il Benessere del Paziente con Obesità (C.I.B.O), Unità di Endocrinologia, Diabetologia e Andrologia, Dipartimento di Medicina Clinica e Chirurgia, Università degli Studi di Napoli Federico II, Via Sergio Pansini 5, 80131 Naples, Italy
- Unità di Endocrinologia, Diabetologia e Andrologia, Dipartimento di Medicina Clinica e Chirurgia, Università degli Studi di Napoli Federico II, Via Sergio Pansini 5, 80131 Naples, Italy
| | - Devjit Tripathy
- Division of Diabetes UT Health and ALM VA Hospital, San Antonio, TX 78229, USA
| | - Silvia Savastano
- Centro Italiano per la Cura e il Benessere del Paziente con Obesità (C.I.B.O), Unità di Endocrinologia, Diabetologia e Andrologia, Dipartimento di Medicina Clinica e Chirurgia, Università degli Studi di Napoli Federico II, Via Sergio Pansini 5, 80131 Naples, Italy
- Unità di Endocrinologia, Diabetologia e Andrologia, Dipartimento di Medicina Clinica e Chirurgia, Università degli Studi di Napoli Federico II, Via Sergio Pansini 5, 80131 Naples, Italy
| | - Annamaria Colao
- Centro Italiano per la Cura e il Benessere del Paziente con Obesità (C.I.B.O), Unità di Endocrinologia, Diabetologia e Andrologia, Dipartimento di Medicina Clinica e Chirurgia, Università degli Studi di Napoli Federico II, Via Sergio Pansini 5, 80131 Naples, Italy
- Unità di Endocrinologia, Diabetologia e Andrologia, Dipartimento di Medicina Clinica e Chirurgia, Università degli Studi di Napoli Federico II, Via Sergio Pansini 5, 80131 Naples, Italy
- Cattedra Unesco “Educazione Alla Salute e Allo Sviluppo Sostenibile”, Università degli Studi di Napoli Federico II, Via Sergio Pansini 5, 80131 Naples, Italy
| | - Giovanna Muscogiuri
- Centro Italiano per la Cura e il Benessere del Paziente con Obesità (C.I.B.O), Unità di Endocrinologia, Diabetologia e Andrologia, Dipartimento di Medicina Clinica e Chirurgia, Università degli Studi di Napoli Federico II, Via Sergio Pansini 5, 80131 Naples, Italy
- Unità di Endocrinologia, Diabetologia e Andrologia, Dipartimento di Medicina Clinica e Chirurgia, Università degli Studi di Napoli Federico II, Via Sergio Pansini 5, 80131 Naples, Italy
- Cattedra Unesco “Educazione Alla Salute e Allo Sviluppo Sostenibile”, Università degli Studi di Napoli Federico II, Via Sergio Pansini 5, 80131 Naples, Italy
| |
Collapse
|
6
|
Feldman F, Koudoufio M, El-Jalbout R, Sauvé MF, Ahmarani L, Sané AT, Ould-Chikh NEH, N’Timbane T, Patey N, Desjardins Y, Stintzi A, Spahis S, Levy E. Cranberry Proanthocyanidins as a Therapeutic Strategy to Curb Metabolic Syndrome and Fatty Liver-Associated Disorders. Antioxidants (Basel) 2022; 12:antiox12010090. [PMID: 36670951 PMCID: PMC9854780 DOI: 10.3390/antiox12010090] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/04/2022] [Revised: 12/26/2022] [Accepted: 12/26/2022] [Indexed: 01/03/2023] Open
Abstract
While the prevalence of metabolic syndrome (MetS) is steadily increasing worldwide, no optimal pharmacotherapy is readily available to address its multifaceted risk factors and halt its complications. This growing challenge mandates the development of other future curative directions. The purpose of the present study is to investigate the efficacy of cranberry proanthocyanidins (PACs) in improving MetS pathological conditions and liver complications; C57BL/6J mice were fed either a standard chow or a high fat/high sucrose (HFHS) diet with and without PACs (200 mg/kg), delivered by daily gavage for 12 weeks. Our results show that PACs lowered HFHS-induced obesity, insulin resistance, and hyperlipidemia. In conjunction, PACs lessened circulatory markers of oxidative stress (OxS) and inflammation. Similarly, the anti-oxidative and anti-inflammatory capacities of PACs were noted in the liver in association with improved hepatic steatosis. Inhibition of lipogenesis and stimulation of beta-oxidation could account for PACs-mediated decline of fatty liver as evidenced not only by the expression of rate-limiting enzymes but also by the status of AMPKα (the key sensor of cellular energy) and the powerful transcription factors (PPARα, PGC1α, SREBP1c, ChREBP). Likewise, treatment with PACs resulted in the downregulation of critical enzymes of liver gluconeogenesis, a process contributing to increased rates of glucose production in type 2 diabetes. Our findings demonstrate that PACs prevented obesity and improved insulin resistance likely via suppression of OxS and inflammation while diminishing hyperlipidemia and fatty liver disease, as clear evidence for their strength of fighting the cluster of MetS abnormalities.
Collapse
Affiliation(s)
- Francis Feldman
- Research Centre, Sainte-Justine University Health Center, Montreal, QC H3T 1C5, Canada
- Department of Nutrition, Université de Montréal, Montreal, QC H3T 1J4, Canada
| | - Mireille Koudoufio
- Research Centre, Sainte-Justine University Health Center, Montreal, QC H3T 1C5, Canada
- Department of Nutrition, Université de Montréal, Montreal, QC H3T 1J4, Canada
| | - Ramy El-Jalbout
- Research Centre, Sainte-Justine University Health Center, Montreal, QC H3T 1C5, Canada
- Department of Radiology, Université de Montréal, Montreal, QC H3T 1J4, Canada
| | - Mathilde Foisy Sauvé
- Research Centre, Sainte-Justine University Health Center, Montreal, QC H3T 1C5, Canada
- Department of Nutrition, Université de Montréal, Montreal, QC H3T 1J4, Canada
| | - Lena Ahmarani
- Research Centre, Sainte-Justine University Health Center, Montreal, QC H3T 1C5, Canada
| | - Alain Théophile Sané
- Research Centre, Sainte-Justine University Health Center, Montreal, QC H3T 1C5, Canada
| | | | - Thierry N’Timbane
- Research Centre, Sainte-Justine University Health Center, Montreal, QC H3T 1C5, Canada
| | - Natalie Patey
- Research Centre, Sainte-Justine University Health Center, Montreal, QC H3T 1C5, Canada
- Department of Pathology, Université de Montréal, Montreal, QC H3T 1J4, Canada
| | - Yves Desjardins
- Institute of Nutrition and Functional Foods, Laval University, Quebec, QC G1V 4L3, Canada
| | - Alain Stintzi
- Department of Biochemistry, Microbiology, and Immunology, Faculty of Medicine, Ottawa Institute of Systems Biology, University of Ottawa, Ottawa, ON K1H 8M5, Canada
| | - Schohraya Spahis
- Research Centre, Sainte-Justine University Health Center, Montreal, QC H3T 1C5, Canada
- Department of Biochemistry & Molecular Medicine, Université de Montréal, Montreal, QC H3T 1J4, Canada
| | - Emile Levy
- Research Centre, Sainte-Justine University Health Center, Montreal, QC H3T 1C5, Canada
- Department of Nutrition, Université de Montréal, Montreal, QC H3T 1J4, Canada
- Correspondence: ; Tel.: +1-(514)-345-7783
| |
Collapse
|
7
|
Lara-Guzmán ÓJ, Rivera DA, Corrales-Agudelo V, Salazar-Jaramillo L, Gil-Izquierdo Á, Medina S, Oger C, Durand T, Galano JM, Escobar JS, Muñoz-Durango K, Sierra JA. Dietary antioxidant intake is inversely associated with 2,3-dinor oxylipin metabolites, the major excreted oxylipins in overweight and obese subjects. Free Radic Biol Med 2022; 190:42-54. [PMID: 35933054 DOI: 10.1016/j.freeradbiomed.2022.07.023] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/18/2022] [Revised: 07/11/2022] [Accepted: 07/31/2022] [Indexed: 10/16/2022]
Abstract
Cardiometabolic disease risk factors, including obesity, insulin resistance, high blood pressure, and dyslipidemia, are associated with elevated oxidative stress biomarkers like oxylipins. Increased adiposity by itself induces various isomers of this oxidized lipid family, while dietary polyphenols show benefits in its regulation. Previously, we showed that specific co-abundant microorganisms characterized the gut microbiota of Colombians and associated differentially with diet, lifestyle, obesity, and cardiometabolic health status, which led us to hypothesize that urinary oxylipins would reflect the intensity of oxidative metabolism linked to gut microbiota dysbiosis. Thus, we selected a convenience sample of 105 participants (age: 40.2 ± 11.9 years, 47.6% women), grouped according to microbiota, cardiometabolic health status, and body mass index (BMI); and evaluated 33 urinary oxylipins by HPLC-QqQ-MS/MS (e.g., isoprostanes, prostaglandins, and metabolites), paired with anthropometry and blood chemistry information and dietary antioxidants estimated from a 24-h food recall. In general, oxylipins did not show differences among individuals who differed in gut microbiota. While the unmetabolized oxylipin levels were not associated with BMI, the total content of oxylipin metabolites was highest in obese and cardiometabolically abnormal subjects (e.g., insulin resistant), mainly by prostaglandin-D (2,3-dinor-11β-PGF2α) and 15-F2t-IsoPs (2,3-dinor-15-F2t-IsoP and 2,3-dinor-15-epi-15-F2t-IsoP) metabolites. The total polyphenol intake in this cohort was 1070 ± 627 mg/day. After adjusting for body weight, the polyphenol intake was significantly higher in lean than overweight and showed an inverse association with dinor-oxylipin levels in principal component analysis. These results suggest that the 2,3-dinor-oxylipins could be more specific biomarkers associated with BMI than their parent oxylipins and that are sensitive to be regulated by dietary antioxidants.
Collapse
Affiliation(s)
- Óscar J Lara-Guzmán
- Vidarium-Nutrition, Health and Wellness Research Center, Grupo Empresarial Nutresa, Calle 8 sur No. 50-67, Medellin, Colombia
| | - Diego A Rivera
- Vidarium-Nutrition, Health and Wellness Research Center, Grupo Empresarial Nutresa, Calle 8 sur No. 50-67, Medellin, Colombia
| | - Vanessa Corrales-Agudelo
- Vidarium-Nutrition, Health and Wellness Research Center, Grupo Empresarial Nutresa, Calle 8 sur No. 50-67, Medellin, Colombia
| | - Laura Salazar-Jaramillo
- Vidarium-Nutrition, Health and Wellness Research Center, Grupo Empresarial Nutresa, Calle 8 sur No. 50-67, Medellin, Colombia
| | - Ángel Gil-Izquierdo
- Research Group on Quality, Safety, and Bioactivity of Plant Foods, Department of Food Science and Technology, CEBAS (CSIC), P.O. Box 164, 30100, Campus University Espinardo, Murcia, Spain
| | - Sonia Medina
- Research Group on Quality, Safety, and Bioactivity of Plant Foods, Department of Food Science and Technology, CEBAS (CSIC), P.O. Box 164, 30100, Campus University Espinardo, Murcia, Spain
| | - Camille Oger
- Institut des Biomolécules Max Mousseron (IBMM), Pôle Chimi Balard recherché, UMR 5247, CNRS, University of Montpellier, ENSCM, 1919 route de Mende, 34093, Montpellier, France
| | - Thierry Durand
- Institut des Biomolécules Max Mousseron (IBMM), Pôle Chimi Balard recherché, UMR 5247, CNRS, University of Montpellier, ENSCM, 1919 route de Mende, 34093, Montpellier, France
| | - Jean-Marie Galano
- Institut des Biomolécules Max Mousseron (IBMM), Pôle Chimi Balard recherché, UMR 5247, CNRS, University of Montpellier, ENSCM, 1919 route de Mende, 34093, Montpellier, France
| | - Juan S Escobar
- Vidarium-Nutrition, Health and Wellness Research Center, Grupo Empresarial Nutresa, Calle 8 sur No. 50-67, Medellin, Colombia
| | - Katalina Muñoz-Durango
- Vidarium-Nutrition, Health and Wellness Research Center, Grupo Empresarial Nutresa, Calle 8 sur No. 50-67, Medellin, Colombia.
| | - Jelver A Sierra
- Vidarium-Nutrition, Health and Wellness Research Center, Grupo Empresarial Nutresa, Calle 8 sur No. 50-67, Medellin, Colombia.
| |
Collapse
|
8
|
Wisnuwardani RW, De Henauw S, Béghin L, Mesana MI, Gottrand F, Moreno LA, Michels N. Changes in (poly)phenols intake and metabolic syndrome risk over ten years from adolescence to adulthood. Nutr Metab Cardiovasc Dis 2022; 32:1830-1840. [PMID: 35637083 DOI: 10.1016/j.numecd.2022.04.015] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/12/2021] [Revised: 04/17/2022] [Accepted: 04/19/2022] [Indexed: 10/18/2022]
Abstract
BACKGROUND AND AIMS (Poly)phenols might contribute to prevent cardiovascular disease, but limited prospective studies exist among adolescents. This study aimed to evaluate within-subject longitudinal changes in (poly)phenols intakes and food group contributors while also exploring the association with metabolic syndrome risk (MetS) during 10 years of follow up in European adolescents becoming young adults. METHODS AND RESULTS In 164 participants (58% girls, 13-18 y at baseline) from Ghent, Zaragoza and Lille, longitudinal data (2006-2016) on (poly)phenol intake was retrieved via 2 or 3 24 h recalls. Linear and logistic longitudinal regression tested the association of (poly)phenols intake (total and classes) with Mets risk or its components (waist-height-ratio, HDL cholesterol, LDL cholesterol, triglycerides, blood pressure and insulin resistance index), adjusted for age, sex, country and other nutrient intakes. The total (poly)phenols intake was 421 ± 107 mg/day (192 mg/1000 kcal/day) at baseline, while 610 ± 101 mg/day (311 mg/1000 kcal/day) at follow-up. The three major food sources for (poly)phenols were 'chocolate', 'fruit and vegetable juices', 'cakes and biscuits' during adolescence and 'coffee', 'tea' and 'chocolate' during adulthood. Phenolic acid intake was associated with less LDL increase over time, while stilbene intake with a steeper increase in triglycerides over time. CONCLUSIONS Differences in major (poly)phenols contributors over time were partially explained by age-specific dietary changes like increased coffee and tea during adulthood. Some significant (poly)phenols-MetS associations might argue for nutrition-based disease prevention during adolescence, especially since adolescents had low (poly)phenols intake.
Collapse
Affiliation(s)
- Ratih W Wisnuwardani
- Department of Public Health and Primary Care, Faculty of Medicine and Health Sciences, Ghent University, C.Heymanslaan 10 - 4K3, 9000 Ghent, Belgium; Departments of Public Health Nutrition, Faculty of Public Health, Mulawarman University, Samarinda, East Kalimantan, Indonesia.
| | - Stefaan De Henauw
- Department of Public Health and Primary Care, Faculty of Medicine and Health Sciences, Ghent University, C.Heymanslaan 10 - 4K3, 9000 Ghent, Belgium.
| | - Laurent Béghin
- Univ. Lille, Inserm, CHU Lille, CIC 1403 - Centre D'investigation Clinique, F-59000 Lille, France; Univ. Lille, Inserm, CHU Lille, U1286 - INFINITE - Institute for Translational Research in Inflammation, F-59000 Lille, France.
| | - Maria Isabel Mesana
- GENUD (Growth, Exercise, Nutrition and Development) Research Group, Faculty of Health Science, University of Zaragoza, C/Pedro Cerbuna 12, 50009 Zaragoza, Spain.
| | - Frédéric Gottrand
- Univ. Lille, Inserm, CHU Lille, CIC 1403 - Centre D'investigation Clinique, F-59000 Lille, France; Univ. Lille, Inserm, CHU Lille, U1286 - INFINITE - Institute for Translational Research in Inflammation, F-59000 Lille, France.
| | - Luis A Moreno
- GENUD (Growth, Exercise, Nutrition and Development) Research Group, Faculty of Health Science, University of Zaragoza, C/Pedro Cerbuna 12, 50009 Zaragoza, Spain; Instituto Agroalimentario de Aragón (IA2) and Instituto de Investigación Sanitaria de Aragón (IIS Aragón), Spain; Centro de Investigación Biomédica en Red de Fisiopatología de La Obesidad y Nutrición (CIBEROBN), Spain; Instituto de Salud Carlos III, Madrid, Spain.
| | - Nathalie Michels
- Department of Public Health and Primary Care, Faculty of Medicine and Health Sciences, Ghent University, C.Heymanslaan 10 - 4K3, 9000 Ghent, Belgium.
| |
Collapse
|
9
|
Systematic analysis of nutrigenomic effects of polyphenols related to cardiometabolic health in humans - Evidence from untargeted mRNA and miRNA studies. Ageing Res Rev 2022; 79:101649. [PMID: 35595185 DOI: 10.1016/j.arr.2022.101649] [Citation(s) in RCA: 11] [Impact Index Per Article: 5.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/22/2021] [Revised: 04/15/2022] [Accepted: 05/13/2022] [Indexed: 12/12/2022]
Abstract
Cardiovascular and metabolic disorders present major causes of mortality in the ageing population. Polyphenols present in human diets possess cardiometabolic protective properties, however their underlying molecular mechanisms in humans are still not well identified. Even though preclinical and in vitro studies advocate that these bioactives can modulate gene expression, most studies were performed using targeted approaches. With the objective to decipher the molecular mechanisms underlying polyphenols cardiometabolic preventive properties in humans, we performed integrative multi-omic bioinformatic analyses of published studies which reported improvements of cardiometabolic risk factors following polyphenol intake, together with genomic analyses performed using untargeted approach. We identified 5 studies within our criteria and nearly 5000 differentially expressed genes, both mRNAs and miRNAs, in peripheral blood cells. Integrative bioinformatic analyses (e.g. pathway and gene network analyses, identification of transcription factors, correlation of gene expression profiles with those associated with diseases and drug intake) revealed that these genes are involved in the processes such as cell adhesion and mobility, immune system, metabolism, or cell signaling. We also identified 27 miRNAs known to regulate processes such as cell cytoskeleton, chemotaxis, cell signaling, or cell metabolism. Gene expression profiles negatively correlated with expression profiles of cardiovascular disease patients, while a positive correlation was observed with gene expression profiles following intake of drugs against cardiometabolic disorders. These analyses further advocate for health protective effects of these bioactives against age-associated diseases. In conclusion, polyphenols can exert multi-genomic modifications in humans and use of untargeted methods coupled with bioinformatic analyses represent the best approach to decipher molecular mechanisms underlying healthy-ageing effects of these bioactives.
Collapse
|
10
|
Ingesta de polifenoles y riesgo cardiovascular en el ensayo PREDIMED-Plus. Una comparación de diferentes ecuaciones de riesgo. Rev Esp Cardiol 2022. [PMID: 34340911 DOI: 10.1016/j.recesp.2021.06.024] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
|
11
|
Targeting Cardiovascular Diseases by Flavonols: An Update. Nutrients 2022; 14:nu14071439. [PMID: 35406050 PMCID: PMC9003055 DOI: 10.3390/nu14071439] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/23/2022] [Revised: 03/24/2022] [Accepted: 03/28/2022] [Indexed: 12/16/2022] Open
Abstract
Flavonols are one of the most plentiful flavonoid subclasses found in natural products and are extensively used as dietary supplements. Numerous in vitro and in vivo studies have shown the cardioprotective properties of flavonols, especially quercetin. This group of substances exerts positive impacts primarily due to their antiatherogenic, antithrombotic, and antioxidant activities. The potential of flavonols to promote vasodilation and regulation of apoptotic processes in the endothelium are other beneficial effects on the cardiovascular system. Despite promising experimental findings, randomized controlled trials and meta-analyses have yielded inconsistent results on the influence of these substances on human cardiovascular parameters. Thus, this review aims to summarize the most recent clinical data on the intake of these substances and their effects on the cardiovascular system. The present study will help clinicians and other healthcare workers understand the value of flavonol supplementation in both subjects at risk for cardiovascular disease and patients with cardiovascular diseases.
Collapse
|
12
|
WANG J, FU J, CHEN D. Study on the protective effect of Lycopene on ischemia-reperfusion myocardium through Inhibiting the opening of mitochondrial MPTP and the activation of apoptotic pathway. FOOD SCIENCE AND TECHNOLOGY 2022. [DOI: 10.1590/fst.41321] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Affiliation(s)
| | | | - Dan CHEN
- Hubei University of Medicine, China
| |
Collapse
|
13
|
Matsui T. Polyphenols-absorption and occurrence in the body system. FOOD SCIENCE AND TECHNOLOGY RESEARCH 2022. [DOI: 10.3136/fstr.fstr-d-21-00264] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
Affiliation(s)
- Toshiro Matsui
- Department of Bioscience and Biotechnology, Faculty of Agriculture, Graduated School of Kyushu University
| |
Collapse
|
14
|
Condezo-Hoyos L, Gazi C, Pérez-Jiménez J. Design of polyphenol-rich diets in clinical trials: A systematic review. Food Res Int 2021; 149:110655. [PMID: 34600657 DOI: 10.1016/j.foodres.2021.110655] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/17/2021] [Revised: 07/27/2021] [Accepted: 08/17/2021] [Indexed: 11/17/2022]
Abstract
Most randomized clinical trials of polyphenols focus on individual foods. Nevertheless, due to their presence in many foods and in order to reflect a real situation, clinical trials based on polyphenol-rich diets are particularly important. This systematic review explores the characteristics of the polyphenol-rich diets used in intervention studies. The bibliography search for English-language scientific papers was performed in the Elsevier Scopus Database and PUBMED in March 2020, and focused on intervention studies with whole polyphenol-rich diets, establishing several exclusion criteria. In studies fulfilling the requirements, information on the design of the polyphenol-rich diet and associated polyphenol intake was extracted and compared. A total of 5 studies were selected. Among them, substantial differences were found in the design of the polyphenol-rich diets, regarding specific instructions and concerning the foods provided. Similarly, although a median daily polyphenol intake of 2,564 mg/day (17,945 mg/week) was obtained from the studies, which corresponds to a nutritional dose, intake values varied widely both for total polyphenols (the difference between studies reached threefold), and for individual polyphenol intake (for hydroxycinnamic acids, a tenfold difference was found between percentile 25 and percentile 75 values). These differences made the comparison of results difficult and may affected the observed health effects. Thus, despite the relevance of studying polyphenol-rich diets as a whole, this systematic review found substantial differences between the studies performed, making direct comparisons difficult.
Collapse
Affiliation(s)
- Luis Condezo-Hoyos
- Department of Metabolism and Nutrition, Institute of Food Science, Technology and Nutrition (ICTAN-CSIC), Madrid, Spain; Universidad Nacional Agraria la Molina, Facultad de Industrias Alimentarias, Innovative Technology, Food and Health Research Group, La Molina, Lima, Perú
| | - Christina Gazi
- Department of Metabolism and Nutrition, Institute of Food Science, Technology and Nutrition (ICTAN-CSIC), Madrid, Spain
| | - Jara Pérez-Jiménez
- Department of Metabolism and Nutrition, Institute of Food Science, Technology and Nutrition (ICTAN-CSIC), Madrid, Spain.
| |
Collapse
|
15
|
Sinapic Acid Alleviated Inflammation-Induced Intestinal Epithelial Barrier Dysfunction in Lipopolysaccharide- (LPS-) Treated Caco-2 Cells. Mediators Inflamm 2021; 2021:5514075. [PMID: 34539242 PMCID: PMC8443358 DOI: 10.1155/2021/5514075] [Citation(s) in RCA: 29] [Impact Index Per Article: 9.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/21/2021] [Accepted: 08/17/2021] [Indexed: 12/15/2022] Open
Abstract
The integrity and permeability of the intestinal epithelial barrier are important indicators of intestinal health. Impaired intestinal epithelial barrier function and increased intestinal permeability are closely linked to the onset and progression of various intestinal diseases. Sinapic acid (SA) is a phenolic acid that has anti-inflammatory, antihyperglycemic, and antioxidant activities; meanwhile, it is also effective in the protection of inflammatory bowel disease (IBD), but the specific mechanisms remain unclear. Here, we evaluated the anti-inflammatory of SA and investigated its potential therapeutic activity in LPS-induced intestinal epithelial barrier and tight junction (TJ) protein dysfunction. SA improved cell viability; attenuated epithelial permeability; restored the protein and mRNA expression of claudin-1, ZO-1, and occludin; and reversed the redistribution of the ZO-1 and claudin-1 proteins in LPS-treated Caco-2 cells. Moreover, SA reduced the inflammatory response by downregulating the activation of the TLR4/NF-κB pathway and attenuated LPS-induced intestinal barrier dysfunction by decreasing the activation of the MLCK/MLC pathway. This study demonstrated that SA has strong anti-inflammatory activity and can alleviate the occurrence of high intercellular permeability in Caco-2 cells exposed to LPS.
Collapse
|
16
|
Rubín-García M, Vitelli-Storelli F, Toledo E, Castro-Barquero S, Tresserra-Rimbau A, Martínez-González MÁ, Salas-Salvadó J, Corella D, Hernáez Á, Martínez JA, Alonso-Gómez ÁM, Wärnberg J, Vioque J, Romaguera D, López-Miranda J, Estruch R, Bernal-López MR, Lapetra J, Serra-Majem L, Bueno-Cavanillas A, Tur JA, Álvarez-Álvarez L, Pintó X, Gaforio JJ, Matía-Martín P, Vidal J, Vázquez C, Daimiel L, Ros E, Gea A, Manzanares JM, Sorlí JV, Schröder H, Abete I, Tojal-Sierra L, Crespo-Oliva E, González-Botella A, Rayó E, García-Rios A, Gómez-Pérez AM, Santos-Lozano JM, Bartolomé Resano R, Murphy MM, Ortega-Azorin C, Medrano C, Zulet MÁ, Sorto-Sanchez C, Babio N, Fitó M, Lamuela-Raventós RM, Martín-Sánchez V. Polyphenol intake and cardiovascular risk in the PREDIMED-Plus trial. A comparison of different risk equations. ACTA ACUST UNITED AC 2021; 75:401-411. [PMID: 34340911 DOI: 10.1016/j.rec.2021.06.013] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/22/2021] [Accepted: 06/18/2021] [Indexed: 11/18/2022]
Abstract
INTRODUCTION AND OBJECTIVES Quantification of cardiovascular risk has been based on scores such as Framingham, Framingham-REGICOR, SCORE or Life's Simple 7 (LS7). In vitro, animal, and randomized clinical studies have shown that polyphenols may provide benefits to the vascular system and reduce the inflammatory response. However, some clinical-epidemiological studies have yielded inconsistent results. Our aim was to assess the possible association between intake of the various polyphenol classes and established cardiovascular scores. METHODS This cross-sectional analysis involved 6633 PREDIMED-Plus study participants. Food polyphenol content was estimated by a semiquantitative food frequency questionnaire, adjusted for total energy intake according to the residual method. The association between polyphenol intake and cardiovascular risk was tested using linear regression analyses. RESULTS Total polyphenol and flavonoid intake were directly and significantly associated only with the LS7 scale. Intake of lignans was directly and significantly associated with SCORE and LS7 scales, stilbene intake with SCORE, and phenolic acid intake with Framingham and Framingham-REGICOR scores. Other polyphenol classes were associated in a protective and significant manner in Framingham, SCORE and LS7 scores. In women, intake of all the polyphenol classes, except phenolic acids, showed a protective trend in the results of the Framingham, Framingham-REGICOR scores and LS7 scale. CONCLUSIONS An inverse association was found between consumption of the 'other polyphenols' class and, especially among women, with estimated cardiovascular risk. The results were similar to those of Framingham, Framingham-REGICOR and LS7 (after eliminating the diet component) and differed from those of SCORE, but the predictors included were limited in the latter case.
Collapse
Affiliation(s)
- María Rubín-García
- Grupo de investigación en Interacciones Gen-Ambiente y Salud (GIIGAS), Instituto de Biomedicina (IBIOMED), Universidad de León, León, Spain
| | - Facundo Vitelli-Storelli
- Grupo de investigación en Interacciones Gen-Ambiente y Salud (GIIGAS), Instituto de Biomedicina (IBIOMED), Universidad de León, León, Spain.
| | - Estefanía Toledo
- Departamento de Medicina Preventiva y Salud Pública, Instituto de Investigación Sanitaria de Navarra (IdiSNA), Universidad de Navarra, Pamplona, Navarra, Spain; Centro de Investigación Biomédica en Red de Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Spain
| | - Sara Castro-Barquero
- Centro de Investigación Biomédica en Red de Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Spain; Departament de Medicina, Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
| | - Anna Tresserra-Rimbau
- Centro de Investigación Biomédica en Red de Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Spain; Departament de Nutrició, Ciències de l'Alimentació i Gastronomia, Facultat de Farmàcia i Ciències de l'Alimentació i XaRTA, Institut de Recerca en Nutrició i Seguretat Alimentària (INSA-UB), Universitat de Barcelona, Santa Coloma de Gramenet, Barcelona, Spain
| | - Miguel Ángel Martínez-González
- Departamento de Medicina Preventiva y Salud Pública, Instituto de Investigación Sanitaria de Navarra (IdiSNA), Universidad de Navarra, Pamplona, Navarra, Spain; Centro de Investigación Biomédica en Red de Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Spain; Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA, United States
| | - Jordi Salas-Salvadó
- Centro de Investigación Biomédica en Red de Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Spain; Unitat de Nutrició Humana, Departament de Bioquímica i Biotecnologia, Universitat Rovira i Virgili, Reus, Tarragona, Spain; Hospital Universitari Sant Joan de Reus, Reus, Tarragona, Spain; Institut d'Investigació Sanitària Pere Virgili (IISPV), Reus, Tarragona, Spain
| | - Dolores Corella
- Centro de Investigación Biomédica en Red de Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Spain; Departamento de Medicina Preventiva, Universidad de Valencia, Valencia, Spain
| | - Álvaro Hernáez
- Centro de Investigación Biomédica en Red de Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Spain; Equip d'Atenció Primària (EAP) Clot, Institut Català de la Salut, Barcelona, Spain; Centre for Fertility and Health, Norwegian Institute of Public Health, Oslo, Norway
| | - J Alfredo Martínez
- Centro de Investigación Biomédica en Red de Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Spain; Departamento de Ciencias de la Alimentación y Fisiología, Centro de Investigación en Nutrición, Universidad de Navarra, Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Navarra, Spain; Programa de Nutrición de Precisión, Instituto Madrileño de Estudios Avanzados en Alimentación, Campus Excelencia Internacional Universidad Autónoma de Madrid + Consejo Superior de Investigaciones Científicas (IMDEA Food, CEI UAM + CSIC), Madrid, Spain
| | - Ángel M Alonso-Gómez
- Centro de Investigación Biomédica en Red de Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Spain; Instituto de Investigaciones Sanitarias Bioaraba, Área Cardiovascular, Respiratoria y Metabólica; Osakidetza Servicio Vasco de Salud, Hospital Universitario Araba, Universidad del País Vasco UPV/ EHU, Vitoria-Gasteiz, Spain
| | - Julia Wärnberg
- Centro de Investigación Biomédica en Red de Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Spain; Departamento de Enfermería, Universidad de Málaga, Instituto de Investigación Biomédica de Málaga (IBIMA), Málaga, Spain
| | - Jesús Vioque
- Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Spain; Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL-UMH). Alicante, Spain
| | - Dora Romaguera
- Centro de Investigación Biomédica en Red de Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Spain; Instituto de Investigaciones Sanitarias de las Illes Balears (IdISBa), Palma de Mallorca, Balearic Islands, Spain
| | - José López-Miranda
- Centro de Investigación Biomédica en Red de Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Spain; Departamento de Medicina Interna, Instituto de Investigaciones Biomédicas Maimónides de Córdoba (IMIBIC), Hospital Universitario Reina Sofía, Universidad de Córdoba, Cordoba, Spain
| | - Ramon Estruch
- Centro de Investigación Biomédica en Red de Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Spain; Departament de Medicina, Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
| | - M Rosa Bernal-López
- Centro de Investigación Biomédica en Red de Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Spain; Departamento de Medicina Interna, Hospital Regional Universitario de Málaga, Instituto de Investigación Biomédica de Málaga (IBIMA), Malaga, Spain
| | - José Lapetra
- Centro de Investigación Biomédica en Red de Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Spain; Departamento de Medicina Familiar, Unidad de Investigación, Distrito Sanitario Atención Primaria Sevilla, Seville, Spain
| | - Luís Serra-Majem
- Centro de Investigación Biomédica en Red de Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Spain; Instituto Universitario de Investigaciones Biomédicas y Sanitarias (IUIBS), Universidad de Las Palmas de Gran Canaria y Centro Hospitalario Universitario Insular Materno Infantil (CHUIMI), Servicio Canario de Salud, Las Palmas de Gran Canaria, Spain
| | - Aurora Bueno-Cavanillas
- Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Spain; Departamento de Medicina Preventiva y Salud Pública, Universidad de Granada, Granada, Spain
| | - Josep A Tur
- Centro de Investigación Biomédica en Red de Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Spain; Instituto de Investigaciones Sanitarias de las Illes Balears (IdISBa), Palma de Mallorca, Balearic Islands, Spain; Grupo de Investigación en Nutrición Comunitaria y Estrés Oxidativo, Universidad de las Islas Baleares, Palma de Mallorca, Balearic Islands, Spain
| | - Laura Álvarez-Álvarez
- Grupo de investigación en Interacciones Gen-Ambiente y Salud (GIIGAS), Instituto de Biomedicina (IBIOMED), Universidad de León, León, Spain
| | - Xavier Pintó
- Centro de Investigación Biomédica en Red de Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Spain; Unidad de Lípidos y Riesgo Vascular, Medicina Interna, Hospital Universitari de Bellvitge-Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Universidad de Barcelona, Hospitalet de Llobregat, Barcelona, Spain
| | - José J Gaforio
- Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Spain; Departamento de Ciencias de la Salud, Centro de Estudios Avanzados en Olivar y Aceites de Oliva, Universidad de Jaén, Jaén, Spain
| | - Pilar Matía-Martín
- Departamento de Endocrinología y Nutrición, Instituto de Investigación Sanitaria Hospital Clínico San Carlos (IdISSC), Madrid, Spain
| | - Josep Vidal
- Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas (CIBERDEM), Spain; Department of Endocrinology, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic, University of Barcelona, Barcelona, Spain
| | - Clotilde Vázquez
- Centro de Investigación Biomédica en Red de Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Spain; Departamento de Endocrinología y Nutrición, Hospital Fundación Jiménez Díaz, Instituto de Investigaciones Biomédicas IISFJD. Universidad Autónoma, Madrid, Spain
| | - Lidia Daimiel
- Nutritional Control of the Epigenome Group, Precision Nutrition and Obesity Program, Instituto Madrileño de Estudios Avanzados en Alimentación, Campus Excelencia Internacional Universidad Autónoma de Madrid + Consejo Superior de Investigaciones Científicas (IMDEA Food, CEI UAM + CSIC), Madrid, Spain
| | - Emili Ros
- Centro de Investigación Biomédica en Red de Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Spain; Clínica de Lípids, Departament d'Endocrinologia i Nutrició, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic, Barcelona, Spain
| | - Alfredo Gea
- Departamento de Medicina Preventiva y Salud Pública, Instituto de Investigación Sanitaria de Navarra (IdiSNA), Universidad de Navarra, Pamplona, Navarra, Spain
| | - José María Manzanares
- Hospital Universitari Sant Joan de Reus, Reus, Tarragona, Spain; Institut d'Investigació Sanitària Pere Virgili (IISPV), Reus, Tarragona, Spain
| | - Jose V Sorlí
- Centro de Investigación Biomédica en Red de Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Spain; Departamento de Medicina Preventiva, Universidad de Valencia, Valencia, Spain
| | - Helmut Schröder
- Equip d'Atenció Primària (EAP) Clot, Institut Català de la Salut, Barcelona, Spain; Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Spain
| | - Itziar Abete
- Centro de Investigación Biomédica en Red de Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Spain; Departamento de Ciencias de la Alimentación y Fisiología, Centro de Investigación en Nutrición, Universidad de Navarra, Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Navarra, Spain
| | - Lucas Tojal-Sierra
- Centro de Investigación Biomédica en Red de Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Spain; Instituto de Investigaciones Sanitarias Bioaraba, Área Cardiovascular, Respiratoria y Metabólica; Osakidetza Servicio Vasco de Salud, Hospital Universitario Araba, Universidad del País Vasco UPV/ EHU, Vitoria-Gasteiz, Spain
| | - Edelys Crespo-Oliva
- Centro de Investigación Biomédica en Red de Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Spain; Departamento de Enfermería, Universidad de Málaga, Instituto de Investigación Biomédica de Málaga (IBIMA), Málaga, Spain
| | | | - Elena Rayó
- Instituto de Investigaciones Sanitarias de las Illes Balears (IdISBa), Palma de Mallorca, Balearic Islands, Spain
| | - Antonio García-Rios
- Centro de Investigación Biomédica en Red de Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Spain; Departamento de Medicina Interna, Instituto de Investigaciones Biomédicas Maimónides de Córdoba (IMIBIC), Hospital Universitario Reina Sofía, Universidad de Córdoba, Cordoba, Spain
| | - Ana María Gómez-Pérez
- Unidad de Gestión Clínica de Endocrinología y Nutrición, Instituto de Investigación Biomédica de Málaga (IBIMA), Hospital Clínico Virgen de la Victoria, Málaga, Spain
| | - José Manuel Santos-Lozano
- Centro de Investigación Biomédica en Red de Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Spain; Departamento de Medicina Familiar, Unidad de Investigación, Distrito Sanitario Atención Primaria Sevilla, Seville, Spain
| | | | - Michelle M Murphy
- Centro de Investigación Biomédica en Red de Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Spain; Institut d'Investigació Sanitària Pere Virgili (IISPV), Reus, Tarragona, Spain; Facultat de Medicina i Ciències de la Salut. Unitat de Medicina Preventiva i Salut Pública. Universitat Rovira i Virgili, Reus, Tarragona, Spain
| | - Carolina Ortega-Azorin
- Centro de Investigación Biomédica en Red de Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Spain; Departamento de Medicina Preventiva, Universidad de Valencia, Valencia, Spain
| | - Casimira Medrano
- Equip d'Atenció Primària (EAP) Clot, Institut Català de la Salut, Barcelona, Spain
| | - María Ángeles Zulet
- Centro de Investigación Biomédica en Red de Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Spain; Departamento de Ciencias de la Alimentación y Fisiología, Centro de Investigación en Nutrición, Universidad de Navarra, Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Navarra, Spain
| | - Carolina Sorto-Sanchez
- Centro de Investigación Biomédica en Red de Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Spain; Instituto de Investigaciones Sanitarias Bioaraba, Área Cardiovascular, Respiratoria y Metabólica; Osakidetza Servicio Vasco de Salud, Hospital Universitario Araba, Universidad del País Vasco UPV/ EHU, Vitoria-Gasteiz, Spain
| | - Nancy Babio
- Centro de Investigación Biomédica en Red de Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Spain; Unitat de Nutrició Humana, Departament de Bioquímica i Biotecnologia, Universitat Rovira i Virgili, Reus, Tarragona, Spain; Hospital Universitari Sant Joan de Reus, Reus, Tarragona, Spain; Institut d'Investigació Sanitària Pere Virgili (IISPV), Reus, Tarragona, Spain
| | - Montserrat Fitó
- Centro de Investigación Biomédica en Red de Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Spain; Equip d'Atenció Primària (EAP) Clot, Institut Català de la Salut, Barcelona, Spain
| | - Rosa María Lamuela-Raventós
- Centro de Investigación Biomédica en Red de Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Spain; Departament de Nutrició, Ciències de l'Alimentació i Gastronomia, Facultat de Farmàcia i Ciències de l'Alimentació i XaRTA, Institut de Recerca en Nutrició i Seguretat Alimentària (INSA-UB), Universitat de Barcelona, Santa Coloma de Gramenet, Barcelona, Spain
| | - Vicente Martín-Sánchez
- Grupo de investigación en Interacciones Gen-Ambiente y Salud (GIIGAS), Instituto de Biomedicina (IBIOMED), Universidad de León, León, Spain; Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Spain
| |
Collapse
|
17
|
Costabile G, Della Pepa G, Vetrani C, Vitaglione P, Griffo E, Giacco R, Vitale M, Salamone D, Rivellese AA, Annuzzi G, Bozzetto L. An Oily Fish Diet Improves Subclinical Inflammation in People at High Cardiovascular Risk: A Randomized Controlled Study. Molecules 2021; 26:molecules26113369. [PMID: 34199645 PMCID: PMC8199776 DOI: 10.3390/molecules26113369] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/23/2021] [Revised: 05/21/2021] [Accepted: 05/28/2021] [Indexed: 12/21/2022] Open
Abstract
Interest has arisen on the anti-inflammatory action of dietary components, including long-chain n-3 fatty acids (LCn3) and polyphenols (PP). The aim of this study was to evaluate the effects of diets rich in PP and oily fish (high-LCn3 diets) on markers of subclinical inflammation and growth factors in people at high cardiometabolic risk. Individuals with high waist circumference and one more component of metabolic syndrome were randomized to one of the following isoenergetic diets: low LCn3&PP, high LCn3, high PP, high LCn3&PP. Before and after 8 weeks, fasting and postprandial plasma concentrations of hs-CRP and fasting serum concentrations of IL-1β, IL-4, IL-6, IL-10, IL-17, INF-γ, TNF-α, FGF, VEGF, PDGF-ββ, G-CSF, and GM-CSF were determined. An oily fish diet reduced fasting plasma hs-CRP (1.28 ± 12.0, −12.5 ± 6.9, 22.5 ± 33.6, −12.2 ± 11.9; 8-week percent change, Mean ± SEM; low LCn3&PP, high LCn3, high PP, high LCn3&PP group, respectively), postprandial 6h-AUC hs-CRP (4.6 ± 16.3, −18.2 ± 7.2, 26.9 ± 35.1, −11.5 ± 11.8, 8-week percent change) and fasting IL-6 (20.8 ± 18.7, −2.44 ± 12.4, 28.1 ± 17.4, −9.6 ± 10.2), IL-17 (2.40 ± 4.9, −13.3 ± 4.9, 3.8 ± 4.43, −11.5 ± 4.7), and VEGF (−5.7 ± 5.8, −5.6 ± 7.5, 3.5 ± 5.8, −11.1 ± 5.5) (8-week percent change; p < 0.05 for LCn3 effect for all; no significant effect for PP; 2-factor ANOVA). An oily fish diet improved subclinical inflammation, while no significant effect was observed for dietary polyphenols.
Collapse
Affiliation(s)
- Giuseppina Costabile
- Department of Clinical Medicine and Surgery, Federico II University, 80130 Naples, Italy; (G.C.); (G.D.P.); (C.V.); (E.G.); (M.V.); (D.S.); (G.A.); (L.B.)
| | - Giuseppe Della Pepa
- Department of Clinical Medicine and Surgery, Federico II University, 80130 Naples, Italy; (G.C.); (G.D.P.); (C.V.); (E.G.); (M.V.); (D.S.); (G.A.); (L.B.)
| | - Claudia Vetrani
- Department of Clinical Medicine and Surgery, Federico II University, 80130 Naples, Italy; (G.C.); (G.D.P.); (C.V.); (E.G.); (M.V.); (D.S.); (G.A.); (L.B.)
| | - Paola Vitaglione
- Department of Agricultural Sciences, Federico II University, 80055 Portici, Italy;
| | - Ettore Griffo
- Department of Clinical Medicine and Surgery, Federico II University, 80130 Naples, Italy; (G.C.); (G.D.P.); (C.V.); (E.G.); (M.V.); (D.S.); (G.A.); (L.B.)
| | - Rosalba Giacco
- Institute of Food Sciences, National Research Council, 83100 Avellino, Italy;
| | - Marilena Vitale
- Department of Clinical Medicine and Surgery, Federico II University, 80130 Naples, Italy; (G.C.); (G.D.P.); (C.V.); (E.G.); (M.V.); (D.S.); (G.A.); (L.B.)
| | - Dominic Salamone
- Department of Clinical Medicine and Surgery, Federico II University, 80130 Naples, Italy; (G.C.); (G.D.P.); (C.V.); (E.G.); (M.V.); (D.S.); (G.A.); (L.B.)
| | - Angela Albarosa Rivellese
- Department of Clinical Medicine and Surgery, Federico II University, 80130 Naples, Italy; (G.C.); (G.D.P.); (C.V.); (E.G.); (M.V.); (D.S.); (G.A.); (L.B.)
- Correspondence:
| | - Giovanni Annuzzi
- Department of Clinical Medicine and Surgery, Federico II University, 80130 Naples, Italy; (G.C.); (G.D.P.); (C.V.); (E.G.); (M.V.); (D.S.); (G.A.); (L.B.)
| | - Lutgarda Bozzetto
- Department of Clinical Medicine and Surgery, Federico II University, 80130 Naples, Italy; (G.C.); (G.D.P.); (C.V.); (E.G.); (M.V.); (D.S.); (G.A.); (L.B.)
| |
Collapse
|
18
|
Pereira-Caro G, Clifford MN, Polyviou T, Ludwig IA, Alfheeaid H, Moreno-Rojas JM, Garcia AL, Malkova D, Crozier A. Plasma pharmacokinetics of (poly)phenol metabolites and catabolites after ingestion of orange juice by endurance trained men. Free Radic Biol Med 2020; 160:784-795. [PMID: 32927016 DOI: 10.1016/j.freeradbiomed.2020.09.007] [Citation(s) in RCA: 19] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/27/2020] [Revised: 08/27/2020] [Accepted: 09/04/2020] [Indexed: 01/14/2023]
Abstract
The health benefits of orange juice (OJ) consumption are attributed in part to the circulating flavanone phase II metabolites and their microbial-derived ring fission phenolic catabolites. The present study investigated these compounds in the bloodstream after acute intake of 500 mL of OJ. Plasma samples obtained at 0, 1, 2, 3, 4, 5, 6, 7, 8 and 24 h after OJ intake were analysed by HPLC-HR-MS. Eleven flavanone metabolites and 36 phenolic catabolites were identified and quantified in plasma. The main metabolites were hesperetin-3'-sulfate with a peak plasma concentration (Cmax) of 80 nmol/L, followed by hesperetin-7-glucuronide (Cmax 24 nmol/L), hesperetin-3'-glucuronide (Cmax 18 nmol/L) and naringenin-7-glucuronide (Cmax 21 nmol/L). Among the main phenolic catabolites to increase in plasma after OJ consumption were 3'-methoxycinnamic acid-4'-sulfate (Cmax 19 nmol/L), 3-hydroxy-3-(3'-hydroxy-4'-methoxyphenyl)propanoic acid (Cmax 20 nmol/L), 3-(3'-hydroxy-4'-methoxyphenyl)propanoic acid (Cmax 19 nmol/L), 3-(4'-hydroxyphenyl)propanoic acid (Cmax 25 nmol/L), and 3-(phenyl)propanoic acid (Cmax 19 nmol/L), as well as substantial amounts of phenylacetic and hippuric acids. The comprehensive plasma pharmacokinetic profiles that were obtained are of value to the design of future ex vivo cell studies, aimed at elucidating the mechanisms underlying the potential health benefits of OJ consumption. CLINICAL TRIAL REGISTRATION NUMBER: This trial was registered at clinicaltrials.gov as NCT02627547.
Collapse
Affiliation(s)
- Gema Pereira-Caro
- Department of Food and Health, Andalusian Institute of Agricultural and Fishery Research and Training, IFAPA, Alameda Del Obispo, 14004, Córdoba, Spain.
| | - Michael N Clifford
- School of Bioscience and Medicine, Faculty of Health and Medical Sciences University of Surrey, Guildford, GU2 5XH, United Kingdom; Department of Nutrition, Dietetics and Food, Monash University, Notting Hill, VIC, 3168, Australia
| | - Thelma Polyviou
- Human Nutrition, New Lister Building, University of Glasgow, Glasgow Royal Infirmary, 10-16 Alexandra Parade, Glasgow, G31 2ER, UK
| | - Iziar A Ludwig
- Medicinal Chemistry Laboratory, Center for Applied Medicinal Research, University of Navarra, Avda. Pío XII 55, E-31008, Pamplona, Spain
| | - Hani Alfheeaid
- Department of Food Science and Human Nutrition, College of Agriculture and Veterinary Medicine, Qassim University, Saudi Arabia
| | - José Manuel Moreno-Rojas
- Department of Food and Health, Andalusian Institute of Agricultural and Fishery Research and Training, IFAPA, Alameda Del Obispo, 14004, Córdoba, Spain
| | - Ada L Garcia
- Human Nutrition, New Lister Building, University of Glasgow, Glasgow Royal Infirmary, 10-16 Alexandra Parade, Glasgow, G31 2ER, UK
| | - Dalia Malkova
- Human Nutrition, New Lister Building, University of Glasgow, Glasgow Royal Infirmary, 10-16 Alexandra Parade, Glasgow, G31 2ER, UK
| | - Alan Crozier
- School of Medicine, Dentistry and Nursing, University of Glasgow, Glasgow, G12 8QQ, UK; United Kingdom and Department of Nutrition, University of California, Davis, CA, 95616, USA
| |
Collapse
|
19
|
Wang R, Zhu W, Peng J, Li K, Li C. Lipid rafts as potential mechanistic targets underlying the pleiotropic actions of polyphenols. Crit Rev Food Sci Nutr 2020; 62:311-324. [PMID: 32951435 DOI: 10.1080/10408398.2020.1815171] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
Abstract
Polyphenols have attracted a lot of global attention due to their diverse biological actions against cancer, obesity, and cardiovascular diseases. Although extensive research has been carried out to elucidate the mechanisms of pleiotropic actions of polyphenols, this remains unclear. Lipid rafts are distinct nanodomains enriched in cholesterol and sphingolipids, present in the inner and outer leaflets of cell membranes, forming functional platforms for the regulation of cellular processes and diseases. Recent studies focusing on the interaction between polyphenols and cellular lipid rafts shed new light on the pleiotropic actions of polyphenols. Polyphenols are postulated to interact with lipid rafts in two ways: first, they interfere with the structural integrity of lipid rafts, by disrupting their structure and clustering of the ordered domains; second, they modulate the downstream signaling pathways mediated by lipid rafts, by binding to receptor proteins associated with lipid rafts, such as the 67 kDa laminin receptor (67LR), epidermal growth factor receptor (EGFR), and others. This study aims to elaborate the mechanism of interaction between polyphenols and lipid rafts, and describe pleiotropic preventive effects of polyphenols.
Collapse
Affiliation(s)
- Ruifeng Wang
- College of Food Science and Technology, Huazhong Agricultural University, Wuhan, China
| | - Wei Zhu
- College of Food Science and Technology, Huazhong Agricultural University, Wuhan, China
| | - Jinming Peng
- College of Food Science and Technology, Huazhong Agricultural University, Wuhan, China
| | - Kaikai Li
- College of Food Science and Technology, Huazhong Agricultural University, Wuhan, China
| | - Chunmei Li
- College of Food Science and Technology, Huazhong Agricultural University, Wuhan, China.,Key Laboratory of Environment Correlative Food Science, Huazhong Agricultural University, Ministry of Education, Wuhan, China
| |
Collapse
|
20
|
Huang Y, Xiao H, Zhang L, Guo D, Chen S, Qiu X, Hou X. The effect of superfine tea powder addition on the acrylamide content of innovative Xinjiang nang products (tea nang). Food Addit Contam Part A Chem Anal Control Expo Risk Assess 2020; 37:1-18. [PMID: 32530371 DOI: 10.1080/19440049.2020.1769199] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
Abstract
In the present study, tea variety and proportions and tea nang production conditions were optimised to improve tea nang flavour, and dynamic changes in polyphenols and acrylamide content were determined. Orthogonal experimental design was adopted to optimise processing of low-acrylamide tea nang through a multi-index integrated evaluation method (MIEM) and a single-index balanced evaluation method (SBEM). Tea nang acrylamide content, polyphenol content and flavour quality were analysed by HPLC, colorimetry and sensory evaluation, respectively. A 180°C baking temperature, 7% matcha tea powder (MTP) content and 11 min of baking time were optimum. From the 11 kinds of tea from four categories, tea nang with 7% Biluochun tea powder exhibited the best comprehensive quality: decreased acrylamide, increased polyphenols, and the highest sensory scores (11.55 μg/kg, 6.1 mg/g and 92, respectively). This tea nang exhibited flavour senses of harmony, a strong tea flavour, and slight sweetness in back.
Collapse
Affiliation(s)
- Ying Huang
- College of Life Science, Tarim University , Alar, Xinjiang, PR China.,Xinjiang Product and Construction Group Key Laboratory of Agricultural Products Processing in Xinjiang South , Alar, Xinjiang South, China
| | - Haibing Xiao
- Key laboratory of Comprehensive Control of Crop Pests, Tarim University , Alar, Xinjiang, PR China
| | - Li Zhang
- College of Life Science, Tarim University , Alar, Xinjiang, PR China.,Xinjiang Product and Construction Group Key Laboratory of Agricultural Products Processing in Xinjiang South , Alar, Xinjiang South, China
| | - Dongqi Guo
- College of Life Science, Tarim University , Alar, Xinjiang, PR China.,Xinjiang Product and Construction Group Key Laboratory of Agricultural Products Processing in Xinjiang South , Alar, Xinjiang South, China.,College of Biosystems Engineering and Food Science, Zhejiang University , Hangzhou, PR China
| | - Shenghuizi Chen
- College of Life Science, Tarim University , Alar, Xinjiang, PR China.,Xinjiang Product and Construction Group Key Laboratory of Agricultural Products Processing in Xinjiang South , Alar, Xinjiang South, China
| | - Xiaoyan Qiu
- College of Life Science, Tarim University , Alar, Xinjiang, PR China
| | - Xujie Hou
- College of Life Science, Tarim University , Alar, Xinjiang, PR China.,Xinjiang Product and Construction Group Key Laboratory of Agricultural Products Processing in Xinjiang South , Alar, Xinjiang South, China
| |
Collapse
|
21
|
New players in the relationship between diet and microbiota: the role of macromolecular antioxidant polyphenols. Eur J Nutr 2020; 60:1403-1413. [PMID: 32719985 DOI: 10.1007/s00394-020-02339-5] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/30/2020] [Accepted: 07/21/2020] [Indexed: 01/08/2023]
Abstract
PURPOSE Solid evidence has emerged supporting the role of polyphenols and fibers as gut microbiota modulators. These studies have been limited to the data available in food composition databases, which did not include the food content of non-extractable polyphenols (NEPP). The main objective of this work is to quantify the intake of the different types of dietary polyphenols including NEPP and to evaluate their impact on the composition and activity of the intestinal microbiota. METHODS Cross-sectional descriptive study conducted on a sample of 147 adults with no declared pathologies. Dietary intake has been registered by a semi-quantitative Food Frequency Questionnaire (FFQ) and transformed into extractable (EPP) and NEPP, and dietary fibers based on available databases. Major phylogenetic types of the intestinal microbiota were determined by qPCR and fecal SCFA quantification was performed by gas chromatography. RESULTS NEPP account for two-thirds of the total polyphenols intake. A combined analysis by stepwise regression model including all dietary fiber and (poly)phenols has identified hydrolysable (poly)phenol (HPP) intake, as the best predictor of Bacteroides-Prevotella-Porphyromonas group and Bifidobacterium levels in feces. Also, HPPs were positively associated with butyric acid, while insoluble fiber was identified as a predictor of propionic acid in feces. CONCLUSION The intake of macromolecular (poly)phenols could contribute to modulate the gut microbiota by increasing the levels of certain intestinal microorganisms with proven health benefits.
Collapse
|
22
|
Vetrani C, Maukonen J, Bozzetto L, Della Pepa G, Vitale M, Costabile G, Riccardi G, Rivellese AA, Saarela M, Annuzzi G. Diets naturally rich in polyphenols and/or long-chain n-3 polyunsaturated fatty acids differently affect microbiota composition in high-cardiometabolic-risk individuals. Acta Diabetol 2020; 57:853-860. [PMID: 32114641 DOI: 10.1007/s00592-020-01494-9] [Citation(s) in RCA: 32] [Impact Index Per Article: 8.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/08/2019] [Accepted: 01/30/2020] [Indexed: 12/14/2022]
Abstract
AIMS Gut microbiota significantly impacts human health and is influenced by dietary changes. We evaluated the effects of diets naturally rich in polyphenols (PP) and/or long-chain n-3 polyunsaturated fatty acids (LCn3) on microbiota composition in an ancillary analysis of a randomized controlled trial in individuals at high cardiometabolic risk. METHODS Seventy-eight individuals with high waist circumference and at least one additional component of the metabolic syndrome were randomized to an isoenergetic 8-week diet: (a) low LCn3 and PP; (b) high LCn3; (c) high PP; or (d) high LCn3 and PP. Microbiota analysis was performed on feces collected before and after the intervention. DGGE analysis of the predominant bacteria, Eubacterium rectale and Blautia coccoides group (Lachnospiraceae, EREC), Clostridium leptum (Ruminococcaceae, CLEPT), Bacteroides spp., Bifidobacteria, and Lactobacillus group was performed. A quantitative real-time PCR was performed for the same group, additionally including Atopobium cluster (Coriobatteriaceae). Before and after the intervention, participants underwent a 75 g OGTT and a high-fat test meal to evaluate glucose and lipid response. RESULTS Adherence to the four diets was optimal. PP significantly increased microbial diversity (p = 0.006) and CLEPT (p = 0.015), while it reduced EREC (p = 0.044). LCn3 significantly increased the numbers of Bifidobacteria (p = 0.041). Changes in CLEPT numbers correlated with changes in early insulin secretion (r = 0.263, p = 0.030). Changes in Atopobium numbers correlated with postprandial triglycerides in plasma (r = 0.266, p = 0.026) and large VLDL (r = 0.313, p = 0.009), and cholesterol in large VLDL (r = 0.319, p = 0.008). CONCLUSIONS Diets naturally rich in PP or LCn3 influenced gut microbiota composition in individuals at high cardiometabolic risk. These modifications were associated with changes in glucose/lipid metabolism.
Collapse
Affiliation(s)
- Claudia Vetrani
- Department of Clinical Medicine and Surgery, University of Naples "Federico II", 5, Sergio Pansini, 80131, Naples, Italy
- Task Force on Microbiome Studies, University of Naples "Federico II", Naples, Italy
| | - Johanna Maukonen
- VTT Technical Research Centre of Finland, Espoo, Finland
- DuPont Nutrition and Health, Kantvik, Finland
| | - Lutgarda Bozzetto
- Department of Clinical Medicine and Surgery, University of Naples "Federico II", 5, Sergio Pansini, 80131, Naples, Italy
- Task Force on Microbiome Studies, University of Naples "Federico II", Naples, Italy
| | - Giuseppe Della Pepa
- Department of Clinical Medicine and Surgery, University of Naples "Federico II", 5, Sergio Pansini, 80131, Naples, Italy
| | - Marilena Vitale
- Department of Clinical Medicine and Surgery, University of Naples "Federico II", 5, Sergio Pansini, 80131, Naples, Italy
- Task Force on Microbiome Studies, University of Naples "Federico II", Naples, Italy
| | - Giuseppina Costabile
- Department of Clinical Medicine and Surgery, University of Naples "Federico II", 5, Sergio Pansini, 80131, Naples, Italy
- Task Force on Microbiome Studies, University of Naples "Federico II", Naples, Italy
| | - Gabriele Riccardi
- Department of Clinical Medicine and Surgery, University of Naples "Federico II", 5, Sergio Pansini, 80131, Naples, Italy
- Task Force on Microbiome Studies, University of Naples "Federico II", Naples, Italy
| | - Angela Albarosa Rivellese
- Department of Clinical Medicine and Surgery, University of Naples "Federico II", 5, Sergio Pansini, 80131, Naples, Italy.
- Task Force on Microbiome Studies, University of Naples "Federico II", Naples, Italy.
| | - Maria Saarela
- VTT Technical Research Centre of Finland, Espoo, Finland
- South Australian Research and Development Institute, Urrbrae, Australia
| | - Giovanni Annuzzi
- Department of Clinical Medicine and Surgery, University of Naples "Federico II", 5, Sergio Pansini, 80131, Naples, Italy
| |
Collapse
|
23
|
Castro-Barquero S, Tresserra-Rimbau A, Vitelli-Storelli F, Doménech M, Salas-Salvadó J, Martín-Sánchez V, Rubín-García M, Buil-Cosiales P, Corella D, Fitó M, Romaguera D, Vioque J, Alonso-Gómez ÁM, Wärnberg J, Martínez JA, Serra-Majem L, Tinahones FJ, Lapetra J, Pintó X, Tur JA, Garcia-Rios A, García-Molina L, Delgado-Rodriguez M, Matía-Martín P, Daimiel L, Vidal J, Vázquez C, Cofán M, Romanos-Nanclares A, Becerra-Tomas N, Barragan R, Castañer O, Konieczna J, González-Palacios S, Sorto-Sánchez C, Pérez-López J, Zulet MA, Bautista-Castaño I, Casas R, Gómez-Perez AM, Santos-Lozano JM, Rodríguez-Sanchez MÁ, Julibert A, Martín-Calvo N, Hernández-Alonso P, Sorlí JV, Sanllorente A, Galmés-Panadés AM, Cases-Pérez E, Goicolea-Güemez L, Ruiz-Canela M, Babio N, Hernáez Á, Lamuela-Raventós RM, Estruch R. Dietary Polyphenol Intake is Associated with HDL-Cholesterol and A Better Profile of other Components of the Metabolic Syndrome: A PREDIMED-Plus Sub-Study. Nutrients 2020; 12:E689. [PMID: 32143308 PMCID: PMC7146338 DOI: 10.3390/nu12030689] [Citation(s) in RCA: 42] [Impact Index Per Article: 10.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/07/2020] [Revised: 02/28/2020] [Accepted: 02/29/2020] [Indexed: 12/20/2022] Open
Abstract
Dietary polyphenol intake is associated with improvement of metabolic disturbances. The aims of the present study are to describe dietary polyphenol intake in a population with metabolic syndrome (MetS) and to examine the association between polyphenol intake and the components of MetS. This cross-sectional analysis involved 6633 men and women included in the PREDIMED (PREvención con DIeta MEDiterranea-Plus) study. The polyphenol content of foods was estimated from the Phenol-Explorer 3.6 database. The mean of total polyphenol intake was 846 ± 318 mg/day. Except for stilbenes, women had higher polyphenol intake than men. Total polyphenol intake was higher in older participants (>70 years of age) compared to their younger counterparts. Participants with body mass index (BMI) >35 kg/m2 reported lower total polyphenol, flavonoid, and stilbene intake than those with lower BMI. Total polyphenol intake was not associated with a better profile concerning MetS components, except for high-density lipoprotein cholesterol (HDL-c), although stilbenes, lignans, and other polyphenols showed an inverse association with blood pressure, fasting plasma glucose, and triglycerides. A direct association with HDL-c was found for all subclasses except lignans and phenolic acids. To conclude, in participants with MetS, higher intake of several polyphenol subclasses was associated with a better profile of MetS components, especially HDL-c.
Collapse
Grants
- PI13/00673, PI13/00492, PI13/00272, PI13/01123, PI13/00462, PI13/00233, PI13/02184, PI13/00728, PI13/01090, PI13/01056, PI14/01722, PI14/00636, PI14/00618, PI14/00696, PI14/01206, PI14/01919, PI14/00853, PI14/01374, PI14/00972, PI14/00728, PI14/01471, PI1 Fondo de Investigación para la Salud (FIS)
- PI044003 Fundació la Marató de TV3
- AGL2016-75329-R Consejería de Salud de la Junta de Andalucía
- CB06/03 European Regional Development Fund
- 2013ACUP00194 Recercaixa
Collapse
Affiliation(s)
- Sara Castro-Barquero
- Department of Medicine, Faculty of Medicine and Life Sciences, University of Barcelona, Barcelona, Spain. Institut d’Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), 08036 Barcelona, Spain; (S.C.-B.); (M.D.); (R.C.); (Á.H.)
- Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Instituto de Salud Carlos III, 28029 Madrid, Spain (J.S.-S.); (P.B.-C.); (D.C.); (M.F.); (D.R.); (Á.M.A.-G.); (J.W.); (J.A.M.); (L.S.-M.); (F.J.T.); (J.L.); (X.P.); (J.A.T.); (C.V.); (M.C.); (N.B.-T.); (R.B.); (O.C.); (J.K.); (C.S.-S.); (J.P.-L.); (M.A.Z.); (I.B.-C.); (A.M.G.-P.); (J.M.S.-L.); (A.J.); (N.M.-C.); (P.H.-A.); (J.V.S.); (A.S.); (A.M.G.-P.); (L.G.-G.); (M.R.-C.); (N.B.); (R.M.L.-R.)
| | - Anna Tresserra-Rimbau
- Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Instituto de Salud Carlos III, 28029 Madrid, Spain (J.S.-S.); (P.B.-C.); (D.C.); (M.F.); (D.R.); (Á.M.A.-G.); (J.W.); (J.A.M.); (L.S.-M.); (F.J.T.); (J.L.); (X.P.); (J.A.T.); (C.V.); (M.C.); (N.B.-T.); (R.B.); (O.C.); (J.K.); (C.S.-S.); (J.P.-L.); (M.A.Z.); (I.B.-C.); (A.M.G.-P.); (J.M.S.-L.); (A.J.); (N.M.-C.); (P.H.-A.); (J.V.S.); (A.S.); (A.M.G.-P.); (L.G.-G.); (M.R.-C.); (N.B.); (R.M.L.-R.)
- Universitat Rovira i Virgili, Departament de Bioquímica i Biotecnologia, Unitat de Nutrició, 43204 Reus, Spain
- University Hospital of Sant Joan de Reus, Nutrition Unit, 43201 Reus, Spain
- Institut d’Investigació Sanitària Pere Virgili (IISPV), 43201 Reus, Spain
| | - Facundo Vitelli-Storelli
- Institute of Biomedicine (IBIOMED), University of León, 24071 León, Spain; (F.V.-S.); (V.M.-S.); (M.R.-G.)
| | - Mónica Doménech
- Department of Medicine, Faculty of Medicine and Life Sciences, University of Barcelona, Barcelona, Spain. Institut d’Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), 08036 Barcelona, Spain; (S.C.-B.); (M.D.); (R.C.); (Á.H.)
- Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Instituto de Salud Carlos III, 28029 Madrid, Spain (J.S.-S.); (P.B.-C.); (D.C.); (M.F.); (D.R.); (Á.M.A.-G.); (J.W.); (J.A.M.); (L.S.-M.); (F.J.T.); (J.L.); (X.P.); (J.A.T.); (C.V.); (M.C.); (N.B.-T.); (R.B.); (O.C.); (J.K.); (C.S.-S.); (J.P.-L.); (M.A.Z.); (I.B.-C.); (A.M.G.-P.); (J.M.S.-L.); (A.J.); (N.M.-C.); (P.H.-A.); (J.V.S.); (A.S.); (A.M.G.-P.); (L.G.-G.); (M.R.-C.); (N.B.); (R.M.L.-R.)
| | - Jordi Salas-Salvadó
- Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Instituto de Salud Carlos III, 28029 Madrid, Spain (J.S.-S.); (P.B.-C.); (D.C.); (M.F.); (D.R.); (Á.M.A.-G.); (J.W.); (J.A.M.); (L.S.-M.); (F.J.T.); (J.L.); (X.P.); (J.A.T.); (C.V.); (M.C.); (N.B.-T.); (R.B.); (O.C.); (J.K.); (C.S.-S.); (J.P.-L.); (M.A.Z.); (I.B.-C.); (A.M.G.-P.); (J.M.S.-L.); (A.J.); (N.M.-C.); (P.H.-A.); (J.V.S.); (A.S.); (A.M.G.-P.); (L.G.-G.); (M.R.-C.); (N.B.); (R.M.L.-R.)
- Universitat Rovira i Virgili, Departament de Bioquímica i Biotecnologia, Unitat de Nutrició, 43204 Reus, Spain
- University Hospital of Sant Joan de Reus, Nutrition Unit, 43201 Reus, Spain
- Institut d’Investigació Sanitària Pere Virgili (IISPV), 43201 Reus, Spain
| | - Vicente Martín-Sánchez
- Institute of Biomedicine (IBIOMED), University of León, 24071 León, Spain; (F.V.-S.); (V.M.-S.); (M.R.-G.)
- CIBER de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, 28029 Madrid, Spain; (J.V.); (L.G.-M.); (S.G.-P.)
| | - María Rubín-García
- Institute of Biomedicine (IBIOMED), University of León, 24071 León, Spain; (F.V.-S.); (V.M.-S.); (M.R.-G.)
| | - Pilar Buil-Cosiales
- Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Instituto de Salud Carlos III, 28029 Madrid, Spain (J.S.-S.); (P.B.-C.); (D.C.); (M.F.); (D.R.); (Á.M.A.-G.); (J.W.); (J.A.M.); (L.S.-M.); (F.J.T.); (J.L.); (X.P.); (J.A.T.); (C.V.); (M.C.); (N.B.-T.); (R.B.); (O.C.); (J.K.); (C.S.-S.); (J.P.-L.); (M.A.Z.); (I.B.-C.); (A.M.G.-P.); (J.M.S.-L.); (A.J.); (N.M.-C.); (P.H.-A.); (J.V.S.); (A.S.); (A.M.G.-P.); (L.G.-G.); (M.R.-C.); (N.B.); (R.M.L.-R.)
- University of Navarra, Department of Preventive Medicine and Public Health, Instituto de Investigación Sanitaria de Navarra (IdiSNA), 31008 Pamplona, Spain;
- Servicio Navarro de Salud-Osasunbidea-Instituto de Investigación Sanitaria de Navarra (IdiSNA), 31008 Pamplona, Spain
| | - Dolores Corella
- Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Instituto de Salud Carlos III, 28029 Madrid, Spain (J.S.-S.); (P.B.-C.); (D.C.); (M.F.); (D.R.); (Á.M.A.-G.); (J.W.); (J.A.M.); (L.S.-M.); (F.J.T.); (J.L.); (X.P.); (J.A.T.); (C.V.); (M.C.); (N.B.-T.); (R.B.); (O.C.); (J.K.); (C.S.-S.); (J.P.-L.); (M.A.Z.); (I.B.-C.); (A.M.G.-P.); (J.M.S.-L.); (A.J.); (N.M.-C.); (P.H.-A.); (J.V.S.); (A.S.); (A.M.G.-P.); (L.G.-G.); (M.R.-C.); (N.B.); (R.M.L.-R.)
- Department of Preventive Medicine, University of Valencia, 46010 Valencia, Spain
| | - Montserrat Fitó
- Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Instituto de Salud Carlos III, 28029 Madrid, Spain (J.S.-S.); (P.B.-C.); (D.C.); (M.F.); (D.R.); (Á.M.A.-G.); (J.W.); (J.A.M.); (L.S.-M.); (F.J.T.); (J.L.); (X.P.); (J.A.T.); (C.V.); (M.C.); (N.B.-T.); (R.B.); (O.C.); (J.K.); (C.S.-S.); (J.P.-L.); (M.A.Z.); (I.B.-C.); (A.M.G.-P.); (J.M.S.-L.); (A.J.); (N.M.-C.); (P.H.-A.); (J.V.S.); (A.S.); (A.M.G.-P.); (L.G.-G.); (M.R.-C.); (N.B.); (R.M.L.-R.)
- Cardiovascular Risk and Nutrition Research group, Institut Hospital del Mar de Investigaciones Médicas (IMIM), 08007 Barcelona, Spain
| | - Dora Romaguera
- Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Instituto de Salud Carlos III, 28029 Madrid, Spain (J.S.-S.); (P.B.-C.); (D.C.); (M.F.); (D.R.); (Á.M.A.-G.); (J.W.); (J.A.M.); (L.S.-M.); (F.J.T.); (J.L.); (X.P.); (J.A.T.); (C.V.); (M.C.); (N.B.-T.); (R.B.); (O.C.); (J.K.); (C.S.-S.); (J.P.-L.); (M.A.Z.); (I.B.-C.); (A.M.G.-P.); (J.M.S.-L.); (A.J.); (N.M.-C.); (P.H.-A.); (J.V.S.); (A.S.); (A.M.G.-P.); (L.G.-G.); (M.R.-C.); (N.B.); (R.M.L.-R.)
- Health Research Institute of the Balearic Islands (IdISBa), University Hospital Son Espases (Research Unit), 07120 Palma de Mallorca, Spain
| | - Jesús Vioque
- CIBER de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, 28029 Madrid, Spain; (J.V.); (L.G.-M.); (S.G.-P.)
- Miguel Hernandez University, ISABIAL-FISABIO, 03010 Alicante, Spain;
| | - Ángel María Alonso-Gómez
- Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Instituto de Salud Carlos III, 28029 Madrid, Spain (J.S.-S.); (P.B.-C.); (D.C.); (M.F.); (D.R.); (Á.M.A.-G.); (J.W.); (J.A.M.); (L.S.-M.); (F.J.T.); (J.L.); (X.P.); (J.A.T.); (C.V.); (M.C.); (N.B.-T.); (R.B.); (O.C.); (J.K.); (C.S.-S.); (J.P.-L.); (M.A.Z.); (I.B.-C.); (A.M.G.-P.); (J.M.S.-L.); (A.J.); (N.M.-C.); (P.H.-A.); (J.V.S.); (A.S.); (A.M.G.-P.); (L.G.-G.); (M.R.-C.); (N.B.); (R.M.L.-R.)
- Bioaraba Health Research Institute; Osakidetza Basque Health Service, Araba University Hospital; University of the Basque Country UPV/EHU, 01009 Vitoria-Gasteiz, Spain
| | - Julia Wärnberg
- Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Instituto de Salud Carlos III, 28029 Madrid, Spain (J.S.-S.); (P.B.-C.); (D.C.); (M.F.); (D.R.); (Á.M.A.-G.); (J.W.); (J.A.M.); (L.S.-M.); (F.J.T.); (J.L.); (X.P.); (J.A.T.); (C.V.); (M.C.); (N.B.-T.); (R.B.); (O.C.); (J.K.); (C.S.-S.); (J.P.-L.); (M.A.Z.); (I.B.-C.); (A.M.G.-P.); (J.M.S.-L.); (A.J.); (N.M.-C.); (P.H.-A.); (J.V.S.); (A.S.); (A.M.G.-P.); (L.G.-G.); (M.R.-C.); (N.B.); (R.M.L.-R.)
- Department of Nursing. University of Málaga, Instituto de Investigación Biomédica de Málaga (IBIMA), 29010 Málaga, Spain
| | - José Alfredo Martínez
- Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Instituto de Salud Carlos III, 28029 Madrid, Spain (J.S.-S.); (P.B.-C.); (D.C.); (M.F.); (D.R.); (Á.M.A.-G.); (J.W.); (J.A.M.); (L.S.-M.); (F.J.T.); (J.L.); (X.P.); (J.A.T.); (C.V.); (M.C.); (N.B.-T.); (R.B.); (O.C.); (J.K.); (C.S.-S.); (J.P.-L.); (M.A.Z.); (I.B.-C.); (A.M.G.-P.); (J.M.S.-L.); (A.J.); (N.M.-C.); (P.H.-A.); (J.V.S.); (A.S.); (A.M.G.-P.); (L.G.-G.); (M.R.-C.); (N.B.); (R.M.L.-R.)
- Department of Nutrition, Food Sciences, and Physiology, Center for Nutrition Research, University of Navarra, 31008 Pamplona, Spain
- Precision Nutrition Program, IMDEA Food, CEI UAM + CSIC, 28049 Madrid, Spain;
| | - Luís Serra-Majem
- Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Instituto de Salud Carlos III, 28029 Madrid, Spain (J.S.-S.); (P.B.-C.); (D.C.); (M.F.); (D.R.); (Á.M.A.-G.); (J.W.); (J.A.M.); (L.S.-M.); (F.J.T.); (J.L.); (X.P.); (J.A.T.); (C.V.); (M.C.); (N.B.-T.); (R.B.); (O.C.); (J.K.); (C.S.-S.); (J.P.-L.); (M.A.Z.); (I.B.-C.); (A.M.G.-P.); (J.M.S.-L.); (A.J.); (N.M.-C.); (P.H.-A.); (J.V.S.); (A.S.); (A.M.G.-P.); (L.G.-G.); (M.R.-C.); (N.B.); (R.M.L.-R.)
- Research Institute of Biomedical and Health Sciences (IUIBS), University of Las Palmas de Gran Canaria & Centro Hospitalario Universitario Insular Materno Infantil (CHUIMI), Canarian Health Service, 35016 Las Palmas de Gran Canaria, Spain
| | - Francisco José Tinahones
- Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Instituto de Salud Carlos III, 28029 Madrid, Spain (J.S.-S.); (P.B.-C.); (D.C.); (M.F.); (D.R.); (Á.M.A.-G.); (J.W.); (J.A.M.); (L.S.-M.); (F.J.T.); (J.L.); (X.P.); (J.A.T.); (C.V.); (M.C.); (N.B.-T.); (R.B.); (O.C.); (J.K.); (C.S.-S.); (J.P.-L.); (M.A.Z.); (I.B.-C.); (A.M.G.-P.); (J.M.S.-L.); (A.J.); (N.M.-C.); (P.H.-A.); (J.V.S.); (A.S.); (A.M.G.-P.); (L.G.-G.); (M.R.-C.); (N.B.); (R.M.L.-R.)
- Virgen de la Victoria Hospital, Department of Endocrinology, Instituto de Investigación Biomédica de Málaga (IBIMA). University of Málaga, 29010 Málaga, Spain
| | - José Lapetra
- Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Instituto de Salud Carlos III, 28029 Madrid, Spain (J.S.-S.); (P.B.-C.); (D.C.); (M.F.); (D.R.); (Á.M.A.-G.); (J.W.); (J.A.M.); (L.S.-M.); (F.J.T.); (J.L.); (X.P.); (J.A.T.); (C.V.); (M.C.); (N.B.-T.); (R.B.); (O.C.); (J.K.); (C.S.-S.); (J.P.-L.); (M.A.Z.); (I.B.-C.); (A.M.G.-P.); (J.M.S.-L.); (A.J.); (N.M.-C.); (P.H.-A.); (J.V.S.); (A.S.); (A.M.G.-P.); (L.G.-G.); (M.R.-C.); (N.B.); (R.M.L.-R.)
- Department of Family Medicine, Research Unit, Distrito Sanitario Atención Primaria Sevilla, 41010 Sevilla, Spain
| | - Xavier Pintó
- Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Instituto de Salud Carlos III, 28029 Madrid, Spain (J.S.-S.); (P.B.-C.); (D.C.); (M.F.); (D.R.); (Á.M.A.-G.); (J.W.); (J.A.M.); (L.S.-M.); (F.J.T.); (J.L.); (X.P.); (J.A.T.); (C.V.); (M.C.); (N.B.-T.); (R.B.); (O.C.); (J.K.); (C.S.-S.); (J.P.-L.); (M.A.Z.); (I.B.-C.); (A.M.G.-P.); (J.M.S.-L.); (A.J.); (N.M.-C.); (P.H.-A.); (J.V.S.); (A.S.); (A.M.G.-P.); (L.G.-G.); (M.R.-C.); (N.B.); (R.M.L.-R.)
- Lipids and Vascular Risk Unit, Internal Medicine, Hospital Universitario de Bellvitge, IDIBELL, Hospitalet de Llobregat, 08908 Barcelona, Spain;
| | - Josep Antonio Tur
- Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Instituto de Salud Carlos III, 28029 Madrid, Spain (J.S.-S.); (P.B.-C.); (D.C.); (M.F.); (D.R.); (Á.M.A.-G.); (J.W.); (J.A.M.); (L.S.-M.); (F.J.T.); (J.L.); (X.P.); (J.A.T.); (C.V.); (M.C.); (N.B.-T.); (R.B.); (O.C.); (J.K.); (C.S.-S.); (J.P.-L.); (M.A.Z.); (I.B.-C.); (A.M.G.-P.); (J.M.S.-L.); (A.J.); (N.M.-C.); (P.H.-A.); (J.V.S.); (A.S.); (A.M.G.-P.); (L.G.-G.); (M.R.-C.); (N.B.); (R.M.L.-R.)
- Health Research Institute of the Balearic Islands (IdISBa), University Hospital Son Espases (Research Unit), 07120 Palma de Mallorca, Spain
- Research Group on Community Nutrition & Oxidative Stress, University of Balearic Islands, 07122 Palma de Mallorca, Spain
| | - Antonio Garcia-Rios
- Department of Internal Medicine, Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Reina Sofia University Hospital, University of Cordoba, 14004 Cordoba, Spain;
| | - Laura García-Molina
- CIBER de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, 28029 Madrid, Spain; (J.V.); (L.G.-M.); (S.G.-P.)
- Department of Preventive Medicine and Public Health, University of Granada, 18016 Granada, Spain
| | - Miguel Delgado-Rodriguez
- Miguel Hernandez University, ISABIAL-FISABIO, 03010 Alicante, Spain;
- Division of Preventive Medicine, Faculty of Medicine, University of Jaén, 23071 Jaén, Spain
| | - Pilar Matía-Martín
- Department of Endocrinology and Nutrition, Instituto de Investigación Sanitaria Hospital Clínico San Carlos (IdISSC), 28040 Madrid, Spain;
| | - Lidia Daimiel
- Precision Nutrition Program, IMDEA Food, CEI UAM + CSIC, 28049 Madrid, Spain;
| | - Josep Vidal
- CIBER Diabetes y Enfermedades Metabólicas (CIBERDEM), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain;
- Department of Endocrinology, Institut d’Investigacions Biomédiques August Pi Sunyer (IDIBAPS), Hospital Clinic, University of Barcelona, 08036 Barcelona, Spain
| | - Clotilde Vázquez
- Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Instituto de Salud Carlos III, 28029 Madrid, Spain (J.S.-S.); (P.B.-C.); (D.C.); (M.F.); (D.R.); (Á.M.A.-G.); (J.W.); (J.A.M.); (L.S.-M.); (F.J.T.); (J.L.); (X.P.); (J.A.T.); (C.V.); (M.C.); (N.B.-T.); (R.B.); (O.C.); (J.K.); (C.S.-S.); (J.P.-L.); (M.A.Z.); (I.B.-C.); (A.M.G.-P.); (J.M.S.-L.); (A.J.); (N.M.-C.); (P.H.-A.); (J.V.S.); (A.S.); (A.M.G.-P.); (L.G.-G.); (M.R.-C.); (N.B.); (R.M.L.-R.)
- Department of Endocrinology and Nutrition, Hospital Fundación Jimenez Díaz, Instituto de Investigaciones Biomédicas IISFJD. University Autonoma, 28040 Madrid, Spain
| | - Montserrat Cofán
- Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Instituto de Salud Carlos III, 28029 Madrid, Spain (J.S.-S.); (P.B.-C.); (D.C.); (M.F.); (D.R.); (Á.M.A.-G.); (J.W.); (J.A.M.); (L.S.-M.); (F.J.T.); (J.L.); (X.P.); (J.A.T.); (C.V.); (M.C.); (N.B.-T.); (R.B.); (O.C.); (J.K.); (C.S.-S.); (J.P.-L.); (M.A.Z.); (I.B.-C.); (A.M.G.-P.); (J.M.S.-L.); (A.J.); (N.M.-C.); (P.H.-A.); (J.V.S.); (A.S.); (A.M.G.-P.); (L.G.-G.); (M.R.-C.); (N.B.); (R.M.L.-R.)
- Lipid Clinic, Department of Endocrinology and Nutrition, Institut d’Investigacions Biomèdiques August Pi Sunyer (IDIBAPS), Hospital Clínic, 08036 Barcelona, Spain
| | - Andrea Romanos-Nanclares
- University of Navarra, Department of Preventive Medicine and Public Health, Instituto de Investigación Sanitaria de Navarra (IdiSNA), 31008 Pamplona, Spain;
| | - Nerea Becerra-Tomas
- Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Instituto de Salud Carlos III, 28029 Madrid, Spain (J.S.-S.); (P.B.-C.); (D.C.); (M.F.); (D.R.); (Á.M.A.-G.); (J.W.); (J.A.M.); (L.S.-M.); (F.J.T.); (J.L.); (X.P.); (J.A.T.); (C.V.); (M.C.); (N.B.-T.); (R.B.); (O.C.); (J.K.); (C.S.-S.); (J.P.-L.); (M.A.Z.); (I.B.-C.); (A.M.G.-P.); (J.M.S.-L.); (A.J.); (N.M.-C.); (P.H.-A.); (J.V.S.); (A.S.); (A.M.G.-P.); (L.G.-G.); (M.R.-C.); (N.B.); (R.M.L.-R.)
- Universitat Rovira i Virgili, Departament de Bioquímica i Biotecnologia, Unitat de Nutrició, 43204 Reus, Spain
- University Hospital of Sant Joan de Reus, Nutrition Unit, 43201 Reus, Spain
- Institut d’Investigació Sanitària Pere Virgili (IISPV), 43201 Reus, Spain
| | - Rocio Barragan
- Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Instituto de Salud Carlos III, 28029 Madrid, Spain (J.S.-S.); (P.B.-C.); (D.C.); (M.F.); (D.R.); (Á.M.A.-G.); (J.W.); (J.A.M.); (L.S.-M.); (F.J.T.); (J.L.); (X.P.); (J.A.T.); (C.V.); (M.C.); (N.B.-T.); (R.B.); (O.C.); (J.K.); (C.S.-S.); (J.P.-L.); (M.A.Z.); (I.B.-C.); (A.M.G.-P.); (J.M.S.-L.); (A.J.); (N.M.-C.); (P.H.-A.); (J.V.S.); (A.S.); (A.M.G.-P.); (L.G.-G.); (M.R.-C.); (N.B.); (R.M.L.-R.)
- Department of Preventive Medicine, University of Valencia, 46010 Valencia, Spain
| | - Olga Castañer
- Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Instituto de Salud Carlos III, 28029 Madrid, Spain (J.S.-S.); (P.B.-C.); (D.C.); (M.F.); (D.R.); (Á.M.A.-G.); (J.W.); (J.A.M.); (L.S.-M.); (F.J.T.); (J.L.); (X.P.); (J.A.T.); (C.V.); (M.C.); (N.B.-T.); (R.B.); (O.C.); (J.K.); (C.S.-S.); (J.P.-L.); (M.A.Z.); (I.B.-C.); (A.M.G.-P.); (J.M.S.-L.); (A.J.); (N.M.-C.); (P.H.-A.); (J.V.S.); (A.S.); (A.M.G.-P.); (L.G.-G.); (M.R.-C.); (N.B.); (R.M.L.-R.)
- Cardiovascular Risk and Nutrition Research group, Institut Hospital del Mar de Investigaciones Médicas (IMIM), 08007 Barcelona, Spain
| | - Jadwiga Konieczna
- Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Instituto de Salud Carlos III, 28029 Madrid, Spain (J.S.-S.); (P.B.-C.); (D.C.); (M.F.); (D.R.); (Á.M.A.-G.); (J.W.); (J.A.M.); (L.S.-M.); (F.J.T.); (J.L.); (X.P.); (J.A.T.); (C.V.); (M.C.); (N.B.-T.); (R.B.); (O.C.); (J.K.); (C.S.-S.); (J.P.-L.); (M.A.Z.); (I.B.-C.); (A.M.G.-P.); (J.M.S.-L.); (A.J.); (N.M.-C.); (P.H.-A.); (J.V.S.); (A.S.); (A.M.G.-P.); (L.G.-G.); (M.R.-C.); (N.B.); (R.M.L.-R.)
- Health Research Institute of the Balearic Islands (IdISBa), University Hospital Son Espases (Research Unit), 07120 Palma de Mallorca, Spain
| | - Sandra González-Palacios
- CIBER de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, 28029 Madrid, Spain; (J.V.); (L.G.-M.); (S.G.-P.)
- Miguel Hernandez University, ISABIAL-FISABIO, 03010 Alicante, Spain;
| | - Carolina Sorto-Sánchez
- Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Instituto de Salud Carlos III, 28029 Madrid, Spain (J.S.-S.); (P.B.-C.); (D.C.); (M.F.); (D.R.); (Á.M.A.-G.); (J.W.); (J.A.M.); (L.S.-M.); (F.J.T.); (J.L.); (X.P.); (J.A.T.); (C.V.); (M.C.); (N.B.-T.); (R.B.); (O.C.); (J.K.); (C.S.-S.); (J.P.-L.); (M.A.Z.); (I.B.-C.); (A.M.G.-P.); (J.M.S.-L.); (A.J.); (N.M.-C.); (P.H.-A.); (J.V.S.); (A.S.); (A.M.G.-P.); (L.G.-G.); (M.R.-C.); (N.B.); (R.M.L.-R.)
- Bioaraba Health Research Institute; Osakidetza Basque Health Service, Araba University Hospital; University of the Basque Country UPV/EHU, 01009 Vitoria-Gasteiz, Spain
| | - Jessica Pérez-López
- Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Instituto de Salud Carlos III, 28029 Madrid, Spain (J.S.-S.); (P.B.-C.); (D.C.); (M.F.); (D.R.); (Á.M.A.-G.); (J.W.); (J.A.M.); (L.S.-M.); (F.J.T.); (J.L.); (X.P.); (J.A.T.); (C.V.); (M.C.); (N.B.-T.); (R.B.); (O.C.); (J.K.); (C.S.-S.); (J.P.-L.); (M.A.Z.); (I.B.-C.); (A.M.G.-P.); (J.M.S.-L.); (A.J.); (N.M.-C.); (P.H.-A.); (J.V.S.); (A.S.); (A.M.G.-P.); (L.G.-G.); (M.R.-C.); (N.B.); (R.M.L.-R.)
- Department of Nursing. University of Málaga, Instituto de Investigación Biomédica de Málaga (IBIMA), 29010 Málaga, Spain
| | - María Angeles Zulet
- Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Instituto de Salud Carlos III, 28029 Madrid, Spain (J.S.-S.); (P.B.-C.); (D.C.); (M.F.); (D.R.); (Á.M.A.-G.); (J.W.); (J.A.M.); (L.S.-M.); (F.J.T.); (J.L.); (X.P.); (J.A.T.); (C.V.); (M.C.); (N.B.-T.); (R.B.); (O.C.); (J.K.); (C.S.-S.); (J.P.-L.); (M.A.Z.); (I.B.-C.); (A.M.G.-P.); (J.M.S.-L.); (A.J.); (N.M.-C.); (P.H.-A.); (J.V.S.); (A.S.); (A.M.G.-P.); (L.G.-G.); (M.R.-C.); (N.B.); (R.M.L.-R.)
- Department of Nutrition, Food Sciences, and Physiology, Center for Nutrition Research, University of Navarra, 31008 Pamplona, Spain
- Precision Nutrition Program, IMDEA Food, CEI UAM + CSIC, 28049 Madrid, Spain;
| | - Inmaculada Bautista-Castaño
- Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Instituto de Salud Carlos III, 28029 Madrid, Spain (J.S.-S.); (P.B.-C.); (D.C.); (M.F.); (D.R.); (Á.M.A.-G.); (J.W.); (J.A.M.); (L.S.-M.); (F.J.T.); (J.L.); (X.P.); (J.A.T.); (C.V.); (M.C.); (N.B.-T.); (R.B.); (O.C.); (J.K.); (C.S.-S.); (J.P.-L.); (M.A.Z.); (I.B.-C.); (A.M.G.-P.); (J.M.S.-L.); (A.J.); (N.M.-C.); (P.H.-A.); (J.V.S.); (A.S.); (A.M.G.-P.); (L.G.-G.); (M.R.-C.); (N.B.); (R.M.L.-R.)
- Research Institute of Biomedical and Health Sciences (IUIBS), University of Las Palmas de Gran Canaria & Centro Hospitalario Universitario Insular Materno Infantil (CHUIMI), Canarian Health Service, 35016 Las Palmas de Gran Canaria, Spain
| | - Rosa Casas
- Department of Medicine, Faculty of Medicine and Life Sciences, University of Barcelona, Barcelona, Spain. Institut d’Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), 08036 Barcelona, Spain; (S.C.-B.); (M.D.); (R.C.); (Á.H.)
- Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Instituto de Salud Carlos III, 28029 Madrid, Spain (J.S.-S.); (P.B.-C.); (D.C.); (M.F.); (D.R.); (Á.M.A.-G.); (J.W.); (J.A.M.); (L.S.-M.); (F.J.T.); (J.L.); (X.P.); (J.A.T.); (C.V.); (M.C.); (N.B.-T.); (R.B.); (O.C.); (J.K.); (C.S.-S.); (J.P.-L.); (M.A.Z.); (I.B.-C.); (A.M.G.-P.); (J.M.S.-L.); (A.J.); (N.M.-C.); (P.H.-A.); (J.V.S.); (A.S.); (A.M.G.-P.); (L.G.-G.); (M.R.-C.); (N.B.); (R.M.L.-R.)
| | - Ana María Gómez-Perez
- Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Instituto de Salud Carlos III, 28029 Madrid, Spain (J.S.-S.); (P.B.-C.); (D.C.); (M.F.); (D.R.); (Á.M.A.-G.); (J.W.); (J.A.M.); (L.S.-M.); (F.J.T.); (J.L.); (X.P.); (J.A.T.); (C.V.); (M.C.); (N.B.-T.); (R.B.); (O.C.); (J.K.); (C.S.-S.); (J.P.-L.); (M.A.Z.); (I.B.-C.); (A.M.G.-P.); (J.M.S.-L.); (A.J.); (N.M.-C.); (P.H.-A.); (J.V.S.); (A.S.); (A.M.G.-P.); (L.G.-G.); (M.R.-C.); (N.B.); (R.M.L.-R.)
- Virgen de la Victoria Hospital, Department of Endocrinology, Instituto de Investigación Biomédica de Málaga (IBIMA). University of Málaga, 29010 Málaga, Spain
| | - José Manuel Santos-Lozano
- Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Instituto de Salud Carlos III, 28029 Madrid, Spain (J.S.-S.); (P.B.-C.); (D.C.); (M.F.); (D.R.); (Á.M.A.-G.); (J.W.); (J.A.M.); (L.S.-M.); (F.J.T.); (J.L.); (X.P.); (J.A.T.); (C.V.); (M.C.); (N.B.-T.); (R.B.); (O.C.); (J.K.); (C.S.-S.); (J.P.-L.); (M.A.Z.); (I.B.-C.); (A.M.G.-P.); (J.M.S.-L.); (A.J.); (N.M.-C.); (P.H.-A.); (J.V.S.); (A.S.); (A.M.G.-P.); (L.G.-G.); (M.R.-C.); (N.B.); (R.M.L.-R.)
- Department of Family Medicine, Research Unit, Distrito Sanitario Atención Primaria Sevilla, 41010 Sevilla, Spain
| | - María Ángeles Rodríguez-Sanchez
- Lipids and Vascular Risk Unit, Internal Medicine, Hospital Universitario de Bellvitge, IDIBELL, Hospitalet de Llobregat, 08908 Barcelona, Spain;
| | - Alicia Julibert
- Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Instituto de Salud Carlos III, 28029 Madrid, Spain (J.S.-S.); (P.B.-C.); (D.C.); (M.F.); (D.R.); (Á.M.A.-G.); (J.W.); (J.A.M.); (L.S.-M.); (F.J.T.); (J.L.); (X.P.); (J.A.T.); (C.V.); (M.C.); (N.B.-T.); (R.B.); (O.C.); (J.K.); (C.S.-S.); (J.P.-L.); (M.A.Z.); (I.B.-C.); (A.M.G.-P.); (J.M.S.-L.); (A.J.); (N.M.-C.); (P.H.-A.); (J.V.S.); (A.S.); (A.M.G.-P.); (L.G.-G.); (M.R.-C.); (N.B.); (R.M.L.-R.)
- Health Research Institute of the Balearic Islands (IdISBa), University Hospital Son Espases (Research Unit), 07120 Palma de Mallorca, Spain
- Research Group on Community Nutrition & Oxidative Stress, University of Balearic Islands, 07122 Palma de Mallorca, Spain
| | - Nerea Martín-Calvo
- Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Instituto de Salud Carlos III, 28029 Madrid, Spain (J.S.-S.); (P.B.-C.); (D.C.); (M.F.); (D.R.); (Á.M.A.-G.); (J.W.); (J.A.M.); (L.S.-M.); (F.J.T.); (J.L.); (X.P.); (J.A.T.); (C.V.); (M.C.); (N.B.-T.); (R.B.); (O.C.); (J.K.); (C.S.-S.); (J.P.-L.); (M.A.Z.); (I.B.-C.); (A.M.G.-P.); (J.M.S.-L.); (A.J.); (N.M.-C.); (P.H.-A.); (J.V.S.); (A.S.); (A.M.G.-P.); (L.G.-G.); (M.R.-C.); (N.B.); (R.M.L.-R.)
- University of Navarra, Department of Preventive Medicine and Public Health, Instituto de Investigación Sanitaria de Navarra (IdiSNA), 31008 Pamplona, Spain;
| | - Pablo Hernández-Alonso
- Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Instituto de Salud Carlos III, 28029 Madrid, Spain (J.S.-S.); (P.B.-C.); (D.C.); (M.F.); (D.R.); (Á.M.A.-G.); (J.W.); (J.A.M.); (L.S.-M.); (F.J.T.); (J.L.); (X.P.); (J.A.T.); (C.V.); (M.C.); (N.B.-T.); (R.B.); (O.C.); (J.K.); (C.S.-S.); (J.P.-L.); (M.A.Z.); (I.B.-C.); (A.M.G.-P.); (J.M.S.-L.); (A.J.); (N.M.-C.); (P.H.-A.); (J.V.S.); (A.S.); (A.M.G.-P.); (L.G.-G.); (M.R.-C.); (N.B.); (R.M.L.-R.)
- Universitat Rovira i Virgili, Departament de Bioquímica i Biotecnologia, Unitat de Nutrició, 43204 Reus, Spain
- University Hospital of Sant Joan de Reus, Nutrition Unit, 43201 Reus, Spain
- Institut d’Investigació Sanitària Pere Virgili (IISPV), 43201 Reus, Spain
- Unidad de Gestión Clínica de Endocrinología y Nutrición del Hospital Virgen de la Victoria, Instituto de Investigación Biomédica de Málaga (IBIMA), 29010 Málaga, Spain
| | - José V Sorlí
- Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Instituto de Salud Carlos III, 28029 Madrid, Spain (J.S.-S.); (P.B.-C.); (D.C.); (M.F.); (D.R.); (Á.M.A.-G.); (J.W.); (J.A.M.); (L.S.-M.); (F.J.T.); (J.L.); (X.P.); (J.A.T.); (C.V.); (M.C.); (N.B.-T.); (R.B.); (O.C.); (J.K.); (C.S.-S.); (J.P.-L.); (M.A.Z.); (I.B.-C.); (A.M.G.-P.); (J.M.S.-L.); (A.J.); (N.M.-C.); (P.H.-A.); (J.V.S.); (A.S.); (A.M.G.-P.); (L.G.-G.); (M.R.-C.); (N.B.); (R.M.L.-R.)
- Department of Preventive Medicine, University of Valencia, 46010 Valencia, Spain
| | - Albert Sanllorente
- Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Instituto de Salud Carlos III, 28029 Madrid, Spain (J.S.-S.); (P.B.-C.); (D.C.); (M.F.); (D.R.); (Á.M.A.-G.); (J.W.); (J.A.M.); (L.S.-M.); (F.J.T.); (J.L.); (X.P.); (J.A.T.); (C.V.); (M.C.); (N.B.-T.); (R.B.); (O.C.); (J.K.); (C.S.-S.); (J.P.-L.); (M.A.Z.); (I.B.-C.); (A.M.G.-P.); (J.M.S.-L.); (A.J.); (N.M.-C.); (P.H.-A.); (J.V.S.); (A.S.); (A.M.G.-P.); (L.G.-G.); (M.R.-C.); (N.B.); (R.M.L.-R.)
- Cardiovascular Risk and Nutrition Research group, Institut Hospital del Mar de Investigaciones Médicas (IMIM), 08007 Barcelona, Spain
| | - Aina María Galmés-Panadés
- Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Instituto de Salud Carlos III, 28029 Madrid, Spain (J.S.-S.); (P.B.-C.); (D.C.); (M.F.); (D.R.); (Á.M.A.-G.); (J.W.); (J.A.M.); (L.S.-M.); (F.J.T.); (J.L.); (X.P.); (J.A.T.); (C.V.); (M.C.); (N.B.-T.); (R.B.); (O.C.); (J.K.); (C.S.-S.); (J.P.-L.); (M.A.Z.); (I.B.-C.); (A.M.G.-P.); (J.M.S.-L.); (A.J.); (N.M.-C.); (P.H.-A.); (J.V.S.); (A.S.); (A.M.G.-P.); (L.G.-G.); (M.R.-C.); (N.B.); (R.M.L.-R.)
- Health Research Institute of the Balearic Islands (IdISBa), University Hospital Son Espases (Research Unit), 07120 Palma de Mallorca, Spain
| | | | - Leire Goicolea-Güemez
- Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Instituto de Salud Carlos III, 28029 Madrid, Spain (J.S.-S.); (P.B.-C.); (D.C.); (M.F.); (D.R.); (Á.M.A.-G.); (J.W.); (J.A.M.); (L.S.-M.); (F.J.T.); (J.L.); (X.P.); (J.A.T.); (C.V.); (M.C.); (N.B.-T.); (R.B.); (O.C.); (J.K.); (C.S.-S.); (J.P.-L.); (M.A.Z.); (I.B.-C.); (A.M.G.-P.); (J.M.S.-L.); (A.J.); (N.M.-C.); (P.H.-A.); (J.V.S.); (A.S.); (A.M.G.-P.); (L.G.-G.); (M.R.-C.); (N.B.); (R.M.L.-R.)
- Bioaraba Health Research Institute; Osakidetza Basque Health Service, Araba University Hospital; University of the Basque Country UPV/EHU, 01009 Vitoria-Gasteiz, Spain
| | - Miguel Ruiz-Canela
- Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Instituto de Salud Carlos III, 28029 Madrid, Spain (J.S.-S.); (P.B.-C.); (D.C.); (M.F.); (D.R.); (Á.M.A.-G.); (J.W.); (J.A.M.); (L.S.-M.); (F.J.T.); (J.L.); (X.P.); (J.A.T.); (C.V.); (M.C.); (N.B.-T.); (R.B.); (O.C.); (J.K.); (C.S.-S.); (J.P.-L.); (M.A.Z.); (I.B.-C.); (A.M.G.-P.); (J.M.S.-L.); (A.J.); (N.M.-C.); (P.H.-A.); (J.V.S.); (A.S.); (A.M.G.-P.); (L.G.-G.); (M.R.-C.); (N.B.); (R.M.L.-R.)
- University of Navarra, Department of Preventive Medicine and Public Health, Instituto de Investigación Sanitaria de Navarra (IdiSNA), 31008 Pamplona, Spain;
| | - Nancy Babio
- Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Instituto de Salud Carlos III, 28029 Madrid, Spain (J.S.-S.); (P.B.-C.); (D.C.); (M.F.); (D.R.); (Á.M.A.-G.); (J.W.); (J.A.M.); (L.S.-M.); (F.J.T.); (J.L.); (X.P.); (J.A.T.); (C.V.); (M.C.); (N.B.-T.); (R.B.); (O.C.); (J.K.); (C.S.-S.); (J.P.-L.); (M.A.Z.); (I.B.-C.); (A.M.G.-P.); (J.M.S.-L.); (A.J.); (N.M.-C.); (P.H.-A.); (J.V.S.); (A.S.); (A.M.G.-P.); (L.G.-G.); (M.R.-C.); (N.B.); (R.M.L.-R.)
- Universitat Rovira i Virgili, Departament de Bioquímica i Biotecnologia, Unitat de Nutrició, 43204 Reus, Spain
- University Hospital of Sant Joan de Reus, Nutrition Unit, 43201 Reus, Spain
- Institut d’Investigació Sanitària Pere Virgili (IISPV), 43201 Reus, Spain
| | - Álvaro Hernáez
- Department of Medicine, Faculty of Medicine and Life Sciences, University of Barcelona, Barcelona, Spain. Institut d’Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), 08036 Barcelona, Spain; (S.C.-B.); (M.D.); (R.C.); (Á.H.)
- Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Instituto de Salud Carlos III, 28029 Madrid, Spain (J.S.-S.); (P.B.-C.); (D.C.); (M.F.); (D.R.); (Á.M.A.-G.); (J.W.); (J.A.M.); (L.S.-M.); (F.J.T.); (J.L.); (X.P.); (J.A.T.); (C.V.); (M.C.); (N.B.-T.); (R.B.); (O.C.); (J.K.); (C.S.-S.); (J.P.-L.); (M.A.Z.); (I.B.-C.); (A.M.G.-P.); (J.M.S.-L.); (A.J.); (N.M.-C.); (P.H.-A.); (J.V.S.); (A.S.); (A.M.G.-P.); (L.G.-G.); (M.R.-C.); (N.B.); (R.M.L.-R.)
| | - Rosa María Lamuela-Raventós
- Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Instituto de Salud Carlos III, 28029 Madrid, Spain (J.S.-S.); (P.B.-C.); (D.C.); (M.F.); (D.R.); (Á.M.A.-G.); (J.W.); (J.A.M.); (L.S.-M.); (F.J.T.); (J.L.); (X.P.); (J.A.T.); (C.V.); (M.C.); (N.B.-T.); (R.B.); (O.C.); (J.K.); (C.S.-S.); (J.P.-L.); (M.A.Z.); (I.B.-C.); (A.M.G.-P.); (J.M.S.-L.); (A.J.); (N.M.-C.); (P.H.-A.); (J.V.S.); (A.S.); (A.M.G.-P.); (L.G.-G.); (M.R.-C.); (N.B.); (R.M.L.-R.)
- Department of Nutrition, Food Science and Gastronomy, XaRTA, INSA, School of Pharmacy and Food Sciences, University of Barcelona, 08028 Barcelona, Spain
| | - Ramon Estruch
- Department of Medicine, Faculty of Medicine and Life Sciences, University of Barcelona, Barcelona, Spain. Institut d’Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), 08036 Barcelona, Spain; (S.C.-B.); (M.D.); (R.C.); (Á.H.)
- Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Instituto de Salud Carlos III, 28029 Madrid, Spain (J.S.-S.); (P.B.-C.); (D.C.); (M.F.); (D.R.); (Á.M.A.-G.); (J.W.); (J.A.M.); (L.S.-M.); (F.J.T.); (J.L.); (X.P.); (J.A.T.); (C.V.); (M.C.); (N.B.-T.); (R.B.); (O.C.); (J.K.); (C.S.-S.); (J.P.-L.); (M.A.Z.); (I.B.-C.); (A.M.G.-P.); (J.M.S.-L.); (A.J.); (N.M.-C.); (P.H.-A.); (J.V.S.); (A.S.); (A.M.G.-P.); (L.G.-G.); (M.R.-C.); (N.B.); (R.M.L.-R.)
- Department of Internal Medicine, Hospital Clinic de Barcelona, 08036 Barcelona, Spain
| |
Collapse
|
24
|
Mirza-Aghazadeh-Attari M, Ekrami EM, Aghdas SAM, Mihanfar A, Hallaj S, Yousefi B, Safa A, Majidinia M. Targeting PI3K/Akt/mTOR signaling pathway by polyphenols: Implication for cancer therapy. Life Sci 2020; 255:117481. [PMID: 32135183 DOI: 10.1016/j.lfs.2020.117481] [Citation(s) in RCA: 58] [Impact Index Per Article: 14.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/22/2019] [Revised: 02/20/2020] [Accepted: 02/28/2020] [Indexed: 02/07/2023]
Abstract
Cancer is one of the biggest challenges facing medicine and its cure is regarded to be the Holy Grail of medicine. Therapy in cancer is consisted as various artificial cytotoxic agents and radiotherapy, and recently immunotherapy. Recently much attention has been directed to the use of natural occurring agents in cancer therapy. One of the main group of agents utilized in this regard is polyphenols which are found abundantly in berries, fruits and vegetables. Polyphenols show to exert direct and indirect effects in progression of cancer, angiogenesis, proliferation and enhancing resistance to treatment. One of the cellular pathways commonly affected by polyphenols is PI3K/Akt/mTOR pathway, which has far ranging effects on multiple key aspects of cellular growth, metabolism and death. In this review article, evidence regarding the biology of polyphenols in cancer via PI3K/Akt/mTOR pathway is discussed and their application on cancer pathophysiology in various types of human malignancies is shown.
Collapse
Affiliation(s)
- Mohammad Mirza-Aghazadeh-Attari
- Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran; Aging Research Institute, Tabriz University of Medical Sciences, Tabriz, Iran
| | - Elyad Mohammadi Ekrami
- Department of Anesthesiology & Critical Care Medicine, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran
| | - Seyyed Ali Mousavi Aghdas
- Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran; Aging Research Institute, Tabriz University of Medical Sciences, Tabriz, Iran
| | - Ainaz Mihanfar
- Department of Biochemistry, Faculty of Medicine, Urmia University of Medical Sciences, Urmia, Iran
| | - Shahin Hallaj
- Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran; Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
| | - Bahman Yousefi
- Molecular Medicine Research Center, Tabriz University of Medical Sciences, Tabriz, Iran; Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
| | - Amin Safa
- Institute of Research and Development, Duy Tan University, Da Nang, Viet Nam; Department of Immunology, Ophthalmology and ENT, School of Medicine, Complutense University, Madrid, Spain
| | - Maryam Majidinia
- Solid Tumor Research Center, Urmia University of Medical Sciences, Urmia, Iran.
| |
Collapse
|
25
|
Bozzetto L, Della Pepa G, Vetrani C, Rivellese AA. Dietary Impact on Postprandial Lipemia. Front Endocrinol (Lausanne) 2020; 11:337. [PMID: 32733374 PMCID: PMC7358426 DOI: 10.3389/fendo.2020.00337] [Citation(s) in RCA: 22] [Impact Index Per Article: 5.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/14/2020] [Accepted: 04/29/2020] [Indexed: 12/14/2022] Open
Abstract
Abnormalities in postprandial lipemia (PPL), particularly those related to triglyceride-rich lipoproteins, are considered an independent cardiovascular risk factor. As diet is known to be one of the main modulators of PPL, the aim of this review was to summarize and discuss current knowledge on the impact of diet and its components on PPL in humans; specifically, the impact of weight loss, different nutrients (quantity and quality of dietary fats, carbohydrates, and proteins), alcohol and other bioactive dietary components (i.e., polyphenols), as well as the effect of different dietary patterns. The possible mechanisms behind the metabolic effects of each dietary component were also discussed.
Collapse
|
26
|
The Bioprotective Effects of Polyphenols on Metabolic Syndrome against Oxidative Stress: Evidences and Perspectives. OXIDATIVE MEDICINE AND CELLULAR LONGEVITY 2019; 2019:6713194. [PMID: 31885810 PMCID: PMC6914975 DOI: 10.1155/2019/6713194] [Citation(s) in RCA: 51] [Impact Index Per Article: 10.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 02/27/2019] [Revised: 05/11/2019] [Accepted: 11/01/2019] [Indexed: 12/25/2022]
Abstract
Polyphenols are the general designation of various kinds of phytochemicals, mainly classified as flavonoids and nonflavonoids. Polyphenolic compounds have been confirmed to exhibit numerous bioactivities and potential health benefits both in vivo and in vitro. Dietary polyphenols have been shown to significantly alleviate several manifestations of metabolic syndrome, namely, central obesity, hypertension, dyslipidemia, and high blood sugar. This review is aimed at discussing the bioprotective effects and related molecular mechanisms of polyphenols, mainly by increasing antioxidant capacity or oxygen scavenging capacity. Polyphenols can exert their antioxidative activity by balancing the organic oxidoreductase enzyme system, regulating antioxidant responsive signaling pathways, and restoring mitochondrial function. These data are helpful for providing new insights into the potential biological effects of polyphenolic compounds and the development of future antioxidant therapeutics.
Collapse
|
27
|
Smiljković M, Kostić M, Stojković D, Glamočlija J, Soković M. Could Flavonoids Compete with Synthetic Azoles in Diminishing Candida albicans Infections? A Comparative Review Based on In Vitro Studies. Curr Med Chem 2019; 26:2536-2554. [PMID: 29956609 DOI: 10.2174/0929867325666180629133218] [Citation(s) in RCA: 13] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/23/2018] [Revised: 05/17/2018] [Accepted: 05/17/2018] [Indexed: 12/11/2022]
Abstract
Flavonoids are polyphenolic compounds with already confirmed various health benefits. This review will shed light on flavonoids as potential antifungals in Candida albicans infections. C. albicans is an opportunistic pathogen able to cause serious health issues due to numerous virulence factors amplifying its pathogenicity. One of the most important virulence factors is Candida ability to form biofilms which are highly resistant to the treatment of antifungal drugs; making diminishing of this pathogen even more challenging. This review will focus on current knowledge on individual flavonoid compounds having the potential to deal with C. albicans in vitro, with special turn on antibiofilm potential and insight into the mode of action, where available. Majority of the commercial drugs for the treatment of candidiasis belong to azole class, so the activity of flavonoids will be compared with the activity of newly synthetized azole compounds, as well as with azole drugs that are already on the market as official therapeutics. This literature review will provide pros and cons for pushing future research towards exploring novel synthetic azoles or further examination of a wide pallet of natural flavonoids.
Collapse
Affiliation(s)
- Marija Smiljković
- Department of Plant Physiology, Institute for Biological Research "Sinisa Stankovic", University of Belgrade, Bulevar Despota Stefana 142, 11000 Belgrade, Serbia
| | - Marina Kostić
- Department of Plant Physiology, Institute for Biological Research "Sinisa Stankovic", University of Belgrade, Bulevar Despota Stefana 142, 11000 Belgrade, Serbia
| | - Dejan Stojković
- Department of Plant Physiology, Institute for Biological Research "Sinisa Stankovic", University of Belgrade, Bulevar Despota Stefana 142, 11000 Belgrade, Serbia
| | - Jasmina Glamočlija
- Department of Plant Physiology, Institute for Biological Research "Sinisa Stankovic", University of Belgrade, Bulevar Despota Stefana 142, 11000 Belgrade, Serbia
| | - Marina Soković
- Department of Plant Physiology, Institute for Biological Research "Sinisa Stankovic", University of Belgrade, Bulevar Despota Stefana 142, 11000 Belgrade, Serbia
| |
Collapse
|
28
|
Cutrim CS, Alvim ID, Cortez MAS. Microencapsulation of green tea polyphenols by ionic gelation and spray chilling methods. Journal of Food Science and Technology 2019; 56:3561-3570. [PMID: 31413383 DOI: 10.1007/s13197-019-03908-1] [Citation(s) in RCA: 13] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Revised: 05/27/2019] [Accepted: 06/28/2019] [Indexed: 02/02/2023]
Abstract
The consumption of teas has been increasing with the dissemination of information regarding the health benefits of its constituents. Obtaining food products with healthier profiles is already a reality for industry with the increasing development of new functional ingredients, including the use of tea and its derivatives (extracts). This work aimed to evaluate the encapsulation of green tea extract powder in lipid microparticles (LMP) by the spray chilling method and in ionic gelation microparticles (IGMP) by the ionic gelation method to obtain polyphenol-rich water insoluble components. Microparticles were adequately obtained in both methods, with typical physical characteristics consistent with the results in literature results, 83.5 ± 2.8% encapsulation efficiency for LMP and 72.6 ± 0.4% for IGMP, and antioxidant activity (IC50 μg/mL) of 33,169.4 ± 123.8 (IGMP) and 2099.7 ± 35.3 (LMP). The microparticles samples were considered suitable as ingredients for add polyphenols in foods.
Collapse
Affiliation(s)
- Camila Sampaio Cutrim
- 1Laboratory of Technology of Dairy Products, Food Technology Department, Faculty of Veterinary Medicine, Fluminense Federal University, Niterói, Rio de Janeiro 24230-340 Brazil
| | - Izabela Dutra Alvim
- 2Cereal and Chocolate Technology Center, Food Technology Institute (ITAL), Brasil Avenue, 2880, Campinas, São Paulo 13070-178 Brazil
| | - Marco Antonio Sloboda Cortez
- 1Laboratory of Technology of Dairy Products, Food Technology Department, Faculty of Veterinary Medicine, Fluminense Federal University, Niterói, Rio de Janeiro 24230-340 Brazil
| |
Collapse
|
29
|
Effects of a diet naturally rich in polyphenols on lipid composition of postprandial lipoproteins in high cardiometabolic risk individuals: an ancillary analysis of a randomized controlled trial. Eur J Clin Nutr 2019; 74:183-192. [PMID: 31249395 DOI: 10.1038/s41430-019-0459-0] [Citation(s) in RCA: 17] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/31/2018] [Revised: 05/24/2019] [Accepted: 06/07/2019] [Indexed: 01/08/2023]
Abstract
BACKGROUND/OBJECTIVES Plasma lipoprotein composition, especially in the postprandial state, could be relevant for cardiovascular risk and could be influenced by eating habits. This study evaluated the effects of a polyphenol-rich diet on postprandial lipoprotein composition in individuals at high cardiometabolic risk. SUBJECTS/METHODS Seventy-eight individuals with high waist circumference and at least another component of the metabolic syndrome were randomized to either a high-polyphenol (HighP) or low-polyphenol (LowP) diet. Before and after the 8-week intervention, chylomicrons, VLDL1, VLDL2, IDL, LDL, HDL particles, and their lipid concentrations were determined over a 6-h high-fat test meal with high or low-polyphenol content, according to the diet assigned. RESULTS VLDL1 postprandial areas under the curve (AUCs) were lower for cholesterol (Chol) (1.48 ± 0.98 vs. 1.91 ± 1.13 mmol/L × 6 h, M ± SD, p = 0.014) and triglycerides (Tg) (4.70 ± 2.70 vs. 6.02 ± 3.07 mmol/L × 6 h, p = 0.005) after the HighP than after the LowP diet, with no changes in Chol/Tg ratio. IDL Chol AUCs were higher after the HighP than after the LowP diet (1.29 ± 0.77 vs. 1.01 ± 0.51 mmol/L × 6 h, p = 0.037). LDL Tg AUCs were higher after the HighP than after the LowP diet (1.15 ± 0.33 vs. 1.02 ± 0.35 mmol/L × 6 h, p < 0.001), with a lower Chol/Tg ratio (14.6 ± 4.0 vs. 16.0 ± 3.8, p = 0.007). HDL Tg AUCs were lower after the HighP than after the LowP diet (1.20 ± 0.41 vs. 1.34 ± 0.37 mmol/L × 6 h, p = 0.013). CONCLUSIONS A high-polyphenol diet reduces the postprandial lipid content of large VLDL and increases IDL cholesterol; it modifies the composition of LDL particles-which become richer in triglycerides, and of HDL-which become instead triglyceride poor. The overall changes in atherogenicity by these effects warrant further investigation on clinical cardiovascular outcomes.
Collapse
|
30
|
Atherogenic Index Reduction and Weight Loss in Metabolic Syndrome Patients Treated with A Novel Pectin-Enriched Formulation of Bergamot Polyphenols. Nutrients 2019; 11:nu11061271. [PMID: 31167512 PMCID: PMC6627641 DOI: 10.3390/nu11061271] [Citation(s) in RCA: 28] [Impact Index Per Article: 5.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/05/2019] [Revised: 05/31/2019] [Accepted: 06/03/2019] [Indexed: 12/17/2022] Open
Abstract
Bergamot flavonoids counteract dyslipidemia and hyperglycemia but fail to induce a significant weight loss. Here, we evaluated the efficacy of bergamot polyphenol extract complex (BPE-C), a novel bergamot juice-derived formulation enriched with flavonoids and pectins, on several metabolic syndrome parameters. Obese patients with atherogenic index of plasma (AIP) over 0.34 and mild hyperglycemia were recruited to a double-blind randomized trial comparing two doses of BPE-C (650 and 1300 mg daily) with placebo. Fifty-two subjects met the inclusion criteria and were assigned to three experimental groups. Fifteen subjects per group completed 90 days-trial. BPE-C reduced significantly fasting glucose by 18.1%, triglycerides by 32% and cholesterol parameters by up to 41.4%, leading to a powerful reduction of AIP (below 0.2) in the high dose group. The homeostasis model assessment of insulin resistance (HOMA-IR) and insulin levels were also reduced. Moreover, BPE-C decreased body weight by 14.8% and body mass index by 15.9% in BPE-C high group. This correlated with a significant reduction of circulating hormones balancing caloric intake, including leptin, ghrelin and upregulation of adiponectin. All effects showed a dose-dependent tendency. This study suggests that food supplements, containing full spectrum of bergamot juice components, such as BPE-C efficiently induce a combination of weight loss and insulin sensitivity effects together with a robust reduction of atherosclerosis risk.
Collapse
|
31
|
A Review of the Science of Colorful, Plant-Based Food and Practical Strategies for "Eating the Rainbow". J Nutr Metab 2019; 2019:2125070. [PMID: 33414957 PMCID: PMC7770496 DOI: 10.1155/2019/2125070] [Citation(s) in RCA: 34] [Impact Index Per Article: 6.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/27/2018] [Revised: 03/27/2019] [Accepted: 04/17/2019] [Indexed: 01/10/2023] Open
Abstract
Over the past decades, thousands of published studies have amassed supporting recommendations to consume fruits and vegetables for physiological and psychological health. Newer research has emerged to suggest that these plant-based foods contain a plethora of not only vitamins and minerals, but perhaps, most importantly, phytonutrients. These phytonutrients have known pleiotropic effects on cellular structure and function, ultimately resulting in the modulation of protein kinases and subsequent epigenetic modification in a manner that leads to improved outcomes. Even though eating fruits and vegetables is a well-known feature of a healthy dietary pattern, population intakes continue to be below federal recommendations. To encourage consumers to include fruits and vegetables into their diet, an “eat by color” approach is proposed in this review. Although each individual food may have numerous effects based on its constituents, the goal of this simplified approach was to identify general patterns of benefits based on the preponderance of scientific data and known mechanisms of food-based constituents. It is suggested that such a consumer-oriented categorization of these plant-based foods may lead to greater recognition of their importance in the daily diet throughout the lifespan. Other adjunctive strategies to heighten awareness of fruits and vegetables are discussed.
Collapse
|
32
|
Wisnuwardani RW, De Henauw S, Forsner M, Gottrand F, Huybrechts I, Knaze V, Kersting M, Donne CL, Manios Y, Marcos A, Molnár D, Rothwell JA, Scalbert A, Sjöström M, Widhalm K, Moreno LA, Michels N. Polyphenol intake and metabolic syndrome risk in European adolescents: the HELENA study. Eur J Nutr 2019; 59:801-812. [PMID: 30903362 DOI: 10.1007/s00394-019-01946-1] [Citation(s) in RCA: 19] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/17/2018] [Accepted: 03/10/2019] [Indexed: 12/19/2022]
Abstract
PURPOSE The role of polyphenol intake during adolescence to prevent metabolic syndrome (MetS) is little explored. This study aimed to evaluate the association between intake of total polyphenols, polyphenol classes and the 10 most consumed individual polyphenols with MetS risk in European adolescents. METHODS Of the cross-sectional HELENA study, 657 adolescents (54% girls; 14.8% overweight; 12.5-17.5 year) had a fasting blood sample and polyphenol intake data from two non-consecutive 24-h recalls matched with the Phenol-Explorer database. MetS was defined via the pediatric American Heart Association definition. Multilevel linear regressions examined the associations of polyphenol quartiles with MetS components, while logistic regression examined the associations with MetS risk. RESULTS After adjusting for all potential confounders (socio-demographics and nine nutrients), total polyphenol intake, polyphenol classes and individual polyphenols were not associated with MetS risk. From all MetS components, only BMI z-score was modestly inversely associated with total polyphenol intake. Further sub analyses on polyphenol classes revealed that flavonoid intake was significantly associated with higher diastolic blood pressure and lower BMI, and phenolic acid intake was associated with higher low-density cholesterol. For individual polyphenols, the above BMI findings were often confirmed (not independent from dietary intake) and a few associations were found with insulin resistance. CONCLUSION Higher intakes of total polyphenols and flavonoids were inversely associated with BMI. No consistent associations were found for other MetS components.
Collapse
Affiliation(s)
- Ratih Wirapuspita Wisnuwardani
- Department of Public Health and Primary Care, Faculty of Medicine and Health Sciences, Ghent University, C.Heymanslaan 10-4K3, 9000, Ghent, Belgium. .,Department of Public Health Nutrition, Faculty of Public Health, Mulawarman University, Samarinda, East Kalimantan, Indonesia.
| | - Stefaan De Henauw
- Department of Public Health and Primary Care, Faculty of Medicine and Health Sciences, Ghent University, C.Heymanslaan 10-4K3, 9000, Ghent, Belgium
| | - Maria Forsner
- Department of Nursing, Umeå University, Umeå, Sweden.,School of Education, Health and Social Sciences, Dalarna University, Falun, Sweden
| | | | - Inge Huybrechts
- Department of Public Health and Primary Care, Faculty of Medicine and Health Sciences, Ghent University, C.Heymanslaan 10-4K3, 9000, Ghent, Belgium.,International Agency for Research on Cancer, World Health Organization, 150 Cours Albert Thomas, 69372, Lyon Cedex 08, France
| | - Viktoria Knaze
- International Agency for Research on Cancer, World Health Organization, 150 Cours Albert Thomas, 69372, Lyon Cedex 08, France
| | - Mathilde Kersting
- Research Department of Child Nutrition, Pediatric University Clinic Bochum, Ruhr-Universität Bochum, Bochum, Germany
| | - Cinzia Le Donne
- CREA Research Centre for Food and Nutrition, Via Ardeatina, 546, 00178, Rome, Italy
| | - Yannis Manios
- Department of Nutrition and Dietetics, Harokopio University, Athens, Greece
| | - Ascensión Marcos
- Immunonutrition Research Group, Department of Metabolism and Nutrition, Institute of Food Science, Technology and Nutrition, Madrid, Spain
| | - Dénes Molnár
- Department of Pediatrics, University of Pécs, Pecs, Hungary
| | - Joseph A Rothwell
- International Agency for Research on Cancer, World Health Organization, 150 Cours Albert Thomas, 69372, Lyon Cedex 08, France
| | - Augustin Scalbert
- International Agency for Research on Cancer, World Health Organization, 150 Cours Albert Thomas, 69372, Lyon Cedex 08, France
| | - Michael Sjöström
- Department of Bioscience and Nutrition, Karolinska Institutet, Stockholm, Sweden
| | - Kurt Widhalm
- Department of Pediatric, Division of Clinical Nutrition, Medical University of Vienna, Vienna, Austria
| | - Luis A Moreno
- GENUD (Growth, Exercise, Nutrition and Development) Research Group, Faculty of Health Science, University of Zaragoza, Edificio del SAI, C/Pedro Cerbuna s/n, 50009, Zaragoza, Spain
| | - Nathalie Michels
- Department of Public Health and Primary Care, Faculty of Medicine and Health Sciences, Ghent University, C.Heymanslaan 10-4K3, 9000, Ghent, Belgium
| |
Collapse
|
33
|
Jaworska D, Mojska H, Gielecińska I, Najman K, Gondek E, Przybylski W, Krzyczkowska P. The effect of vegetable and spice addition on the acrylamide content and antioxidant activity of innovative cereal products. Food Addit Contam Part A Chem Anal Control Expo Risk Assess 2019; 36:374-384. [PMID: 30785367 DOI: 10.1080/19440049.2019.1577991] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
Abstract
The aim of the work was to assess the impact of vegetable and spice addition on the acrylamide content and antioxidant activity of extruded cereal crisps. The foods were based on grain ingredients, such as brown rice, whole grain flour, wheat bran, with different vegetables. Products from one group contained green vegetables, such as broccoli and zucchini; garlic was included as a flavour additive (0.75-1.50%). The second group of crisps consisted of similar cereal ingredients with pumpkin and cinnamon; additionally ginger was included as a flavour additive (0.75-1.50%). The results indicate that the production of a new, innovative product with appropriate nutritional value and acceptable quality is a complex process. The production process significantly changed the nutritional value of the product. The content of acrylamide in zucchini and broccoli crisps was relatively low; ranging from 78 to 86 μg/kg of product. The addition of garlic did not significantly affect the acrylamide content in the final product. For cereal-pumpkin crisps, the acrylamide content was 7 times higher in comparison with zucchini and broccoli products. The acrylamide content in pumpkin and ginger crisps exceeded the benchmark level. The antioxidant activity of the pumpkin product was significantly higher (p < 0.05) than for crisps with green vegetables.
Collapse
Affiliation(s)
- Danuta Jaworska
- a Faculty of Human Nutrition and Consumer Sciences , Warsaw University of Life Sciences , Warsaw , Poland
| | - Hanna Mojska
- b Metabolomics Department , Institute of Food and Nutrition , Warsaw , Poland
| | - Iwona Gielecińska
- b Metabolomics Department , Institute of Food and Nutrition , Warsaw , Poland
| | - Katarzyna Najman
- a Faculty of Human Nutrition and Consumer Sciences , Warsaw University of Life Sciences , Warsaw , Poland
| | - Ewa Gondek
- c Faculty of Food Sciences , Warsaw University of Life Sciences , Warsaw , Poland
| | - Wiesław Przybylski
- a Faculty of Human Nutrition and Consumer Sciences , Warsaw University of Life Sciences , Warsaw , Poland
| | - Patrycja Krzyczkowska
- a Faculty of Human Nutrition and Consumer Sciences , Warsaw University of Life Sciences , Warsaw , Poland
| |
Collapse
|
34
|
Arruda HS, Silva EK, Pereira GA, Angolini CFF, Eberlin MN, Meireles MAA, Pastore GM. Effects of high-intensity ultrasound process parameters on the phenolic compounds recovery from araticum peel. ULTRASONICS SONOCHEMISTRY 2019; 50:82-95. [PMID: 30201331 DOI: 10.1016/j.ultsonch.2018.09.002] [Citation(s) in RCA: 33] [Impact Index Per Article: 6.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/29/2018] [Revised: 08/13/2018] [Accepted: 09/01/2018] [Indexed: 05/20/2023]
Abstract
In this work, we investigated the effects of the nominal ultrasonic power (160-640 W) and process time (0.5-5.0 min) on the phenolic compounds recovery and antioxidant activity from araticum peel. The individual and synergistic effects of the process variables on the phenolic recovery were estimated using a full factorial experimental design. Operating at high nominal ultrasonic powers was possible to obtain high phenolic yields and antioxidant activities at short process times (≤5 min). The HPLC-ESI-QTOF-MS/MS analysis revealed that the araticum peel sample possessed 142 phytochemicals, 123 of which had not been reported in the literature for this raw material yet. The most abundant phenolic compounds recovered were epicatechin, rutin, chlorogenic acid, catechin and ferulic acid. Thus, high-intensity ultrasound technology proved to be a simple, efficient, fast and low environmental impact method for obtaining phenolic compounds from araticum peel. In addition, araticum peel showed to be a promising source bioactive natural phenolics for further applications in the food, nutraceutical, cosmetic and pharmaceutical industries.
Collapse
Affiliation(s)
- Henrique S Arruda
- Bioflavors and Bioactive Compounds Laboratory, Department of Food Science, School of Food Engineering, University of Campinas, Campinas, São Paulo, Brazil
| | - Eric Keven Silva
- LASEFI, Department of Food Engineering, School of Food Engineering, University of Campinas, Campinas, São Paulo, Brazil.
| | - Gustavo A Pereira
- Bioflavors and Bioactive Compounds Laboratory, Department of Food Science, School of Food Engineering, University of Campinas, Campinas, São Paulo, Brazil
| | - Célio Fernando F Angolini
- Bioflavors and Bioactive Compounds Laboratory, Department of Food Science, School of Food Engineering, University of Campinas, Campinas, São Paulo, Brazil
| | - Marcos N Eberlin
- Thomson Mass Spectrometry Laboratory, Institute of Chemistry, University of Campinas, Campinas, São Paulo, Brazil
| | - M Angela A Meireles
- LASEFI, Department of Food Engineering, School of Food Engineering, University of Campinas, Campinas, São Paulo, Brazil
| | - Glaucia M Pastore
- Bioflavors and Bioactive Compounds Laboratory, Department of Food Science, School of Food Engineering, University of Campinas, Campinas, São Paulo, Brazil
| |
Collapse
|
35
|
Adriouch S, Lampuré A, Nechba A, Baudry J, Assmann K, Kesse-Guyot E, Hercberg S, Scalbert A, Touvier M, Fezeu LK. Prospective Association between Total and Specific Dietary Polyphenol Intakes and Cardiovascular Disease Risk in the Nutrinet-Santé French Cohort. Nutrients 2018; 10:E1587. [PMID: 30380657 PMCID: PMC6266343 DOI: 10.3390/nu10111587] [Citation(s) in RCA: 33] [Impact Index Per Article: 5.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/11/2018] [Revised: 10/21/2018] [Accepted: 10/23/2018] [Indexed: 12/31/2022] Open
Abstract
BACKGROUND Epidemiological and experimental evidence support a protective effect of dietary polyphenols on chronic diseases, but high quality longitudinal data are needed, including details on categories of polyphenols. Our objective was to investigate the prospective association between total and individual classes and subclasses of dietary polyphenols and the risk of major cardiovascular disease in the NutriNet-Santé cohort. METHODS A total of 84,158 participants, who completed at least three 24 h dietary records, were included between May 2009 and June 2017. Individual polyphenols intakes were obtained by matching food consumption data from the 24 h dietary records with the Phenol-Explorer polyphenol composition database. Multivariable Cox proportional hazards models were used to characterize the associations between dietary polyphenols and the incidence of cardiovascular diseases, comparing tertile T3 vs. T1 of classes and subclasses of polyphenols. RESULTS Over a median of 4.9 years of follow-up, 602 major cardiovascular events were diagnosed. Intakes of anthocyanins, catechins, and flavonols were strongly inversely associated with cardiovascular disease risk (anthocyanins: Hazard Ratio (HR)for a 1-point increment of 10 mg/day = 0.98 (0.96⁻0.99, p = 0.03, HRT3vs.T1 = 0.66 (0.52⁻0.83), ptrend = 0.0003; catechins: HRfor a 1-point increment of 10 mg/day = 0.98 (0.96⁻0.99), p = 0.02, HRT3vs.T1 = 0.74 (0.60⁻0.91), ptrend = 0.004; flavonols: HRfor a 1-point increment of 10 mg/day = 0.94 (0.90⁻0.99), p = 0.02, HRT3vs.T1 = 0.75 (0.61⁻0.94), ptrend = 0.006). Intakes of dihydrochalcones, proanthocyaninidins, dihydroflavonols, hydroxybenzoic acids, and stilbenes were also associated with a decrease (13%, 19%, 24%, 24%, and 27%, respectively) in cardiovascular disease risk, when comparing tertile T3 to T1. CONCLUSIONS Higher intakes of polyphenols, especially of anthocyanins, catechins, and flavonols, were associated with a statistically significant decreased cardiovascular disease risk.
Collapse
Affiliation(s)
- Solia Adriouch
- Equipe de Recherche en Epidémiologie Nutritionnelle (EREN), Centre de Recherche en Epidémiologie et Statistiques, Université Paris 13, Inserm (U1153), Inra (U1125), Cnam, COMUE Sorbonne Paris Cité, F-93017 Bobigny, France.
| | - Aurélie Lampuré
- Equipe de Recherche en Epidémiologie Nutritionnelle (EREN), Centre de Recherche en Epidémiologie et Statistiques, Université Paris 13, Inserm (U1153), Inra (U1125), Cnam, COMUE Sorbonne Paris Cité, F-93017 Bobigny, France.
| | - Anouar Nechba
- Equipe de Recherche en Epidémiologie Nutritionnelle (EREN), Centre de Recherche en Epidémiologie et Statistiques, Université Paris 13, Inserm (U1153), Inra (U1125), Cnam, COMUE Sorbonne Paris Cité, F-93017 Bobigny, France.
| | - Julia Baudry
- Equipe de Recherche en Epidémiologie Nutritionnelle (EREN), Centre de Recherche en Epidémiologie et Statistiques, Université Paris 13, Inserm (U1153), Inra (U1125), Cnam, COMUE Sorbonne Paris Cité, F-93017 Bobigny, France.
| | - Karen Assmann
- Equipe de Recherche en Epidémiologie Nutritionnelle (EREN), Centre de Recherche en Epidémiologie et Statistiques, Université Paris 13, Inserm (U1153), Inra (U1125), Cnam, COMUE Sorbonne Paris Cité, F-93017 Bobigny, France.
| | - Emmanuelle Kesse-Guyot
- Equipe de Recherche en Epidémiologie Nutritionnelle (EREN), Centre de Recherche en Epidémiologie et Statistiques, Université Paris 13, Inserm (U1153), Inra (U1125), Cnam, COMUE Sorbonne Paris Cité, F-93017 Bobigny, France.
| | - Serge Hercberg
- Equipe de Recherche en Epidémiologie Nutritionnelle (EREN), Centre de Recherche en Epidémiologie et Statistiques, Université Paris 13, Inserm (U1153), Inra (U1125), Cnam, COMUE Sorbonne Paris Cité, F-93017 Bobigny, France.
- Département de Santé Publique, Hôpital Avicenne, F-93017 Bobigny, France.
| | - Augustin Scalbert
- Biomarkers Group, Nutrition and Metabolism Section, International Agency for Research on Cancer (IARC), 69372 Lyon CEDEX 08, France.
| | - Mathilde Touvier
- Equipe de Recherche en Epidémiologie Nutritionnelle (EREN), Centre de Recherche en Epidémiologie et Statistiques, Université Paris 13, Inserm (U1153), Inra (U1125), Cnam, COMUE Sorbonne Paris Cité, F-93017 Bobigny, France.
| | - Léopold K Fezeu
- Equipe de Recherche en Epidémiologie Nutritionnelle (EREN), Centre de Recherche en Epidémiologie et Statistiques, Université Paris 13, Inserm (U1153), Inra (U1125), Cnam, COMUE Sorbonne Paris Cité, F-93017 Bobigny, France.
| |
Collapse
|
36
|
Gutiérrez-Díaz I, Fernández-Navarro T, Salazar N, Bartolomé B, Moreno-Arribas MV, López P, Suárez A, de Los Reyes-Gavilán CG, Gueimonde M, González S. Could Fecal Phenylacetic and Phenylpropionic Acids Be Used as Indicators of Health Status? JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY 2018; 66:10438-10446. [PMID: 30227707 DOI: 10.1021/acs.jafc.8b04102] [Citation(s) in RCA: 24] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/08/2023]
Abstract
Although most of the health effects attributed to polyphenols may be linked to their phenolic-derived metabolites, the role of the intestinal derived-phenolics in human health is still far from being well understood. We determined the profile of fecal phenolic-derived metabolites, microbiota, biomarkers of oxidative stress and inflammation, and daily intake of bioactive compounds in 71 elderly volunteers. Phenylacetic and phenylpropionic acids were the main phenolic metabolites present in feces. From them, phenylacetic acid was related with a more pro-oxidant and immune stimulated status, and both were negatively associated with fecal propionate, whereas phenylpropionic acid was directly related with the fecal concentration of acetate. Moreover, phenylacetic acid was negatively associated with the Bacteroides group and Clostridium cluster XIVa and positively with Lactobacillus. These results provide a rationale to explore the potential of fecal microbial phenolic-derived metabolites as possible biomarkers of health status in future studies focused on the elderly population.
Collapse
Affiliation(s)
- Isabel Gutiérrez-Díaz
- Department of Functional Biology , University of Oviedo , C/Julián Clavería s/n Oviedo , 33006 Asturias , Spain
- Group Diet, Microbiota and Health , Instituto de Investigación Sanitaria del Principado de Asturias (ISPA) , Avda. Roma s/n Oviedo , 33011 Asturias , Spain
| | - Tania Fernández-Navarro
- Department of Functional Biology , University of Oviedo , C/Julián Clavería s/n Oviedo , 33006 Asturias , Spain
- Group Diet, Microbiota and Health , Instituto de Investigación Sanitaria del Principado de Asturias (ISPA) , Avda. Roma s/n Oviedo , 33011 Asturias , Spain
| | - Nuria Salazar
- Group Diet, Microbiota and Health , Instituto de Investigación Sanitaria del Principado de Asturias (ISPA) , Avda. Roma s/n Oviedo , 33011 Asturias , Spain
- Department of Microbiology and Biochemistry of Dairy Products , Instituto de Productos Lácteos de Asturias-Consejo Superior de Investigaciones Científicas (IPLA-CSIC) , Paseo Río Linares s/n Villaviciosa , 33300 Asturias , Spain
| | - Begoña Bartolomé
- Institute of Food Science Research (CIAL), CSIC-UAM, CEI UAM-CSIC , c/Nicolás Cabrera 9 Madrid , 28049 Madrid , Spain
| | - M Victoria Moreno-Arribas
- Institute of Food Science Research (CIAL), CSIC-UAM, CEI UAM-CSIC , c/Nicolás Cabrera 9 Madrid , 28049 Madrid , Spain
| | - Patricia López
- Department of Functional Biology , University of Oviedo , C/Julián Clavería s/n Oviedo , 33006 Asturias , Spain
- Group Basic and Translational Research in Inflammatory Diseases , Instituto de Investigación Sanitaria del Principado de Asturias (ISPA) , Avda. Roma s/n Oviedo , 33011 Asturias , Spain
| | - Ana Suárez
- Department of Functional Biology , University of Oviedo , C/Julián Clavería s/n Oviedo , 33006 Asturias , Spain
- Group Basic and Translational Research in Inflammatory Diseases , Instituto de Investigación Sanitaria del Principado de Asturias (ISPA) , Avda. Roma s/n Oviedo , 33011 Asturias , Spain
| | - Clara G de Los Reyes-Gavilán
- Group Diet, Microbiota and Health , Instituto de Investigación Sanitaria del Principado de Asturias (ISPA) , Avda. Roma s/n Oviedo , 33011 Asturias , Spain
- Department of Microbiology and Biochemistry of Dairy Products , Instituto de Productos Lácteos de Asturias-Consejo Superior de Investigaciones Científicas (IPLA-CSIC) , Paseo Río Linares s/n Villaviciosa , 33300 Asturias , Spain
| | - Miguel Gueimonde
- Group Diet, Microbiota and Health , Instituto de Investigación Sanitaria del Principado de Asturias (ISPA) , Avda. Roma s/n Oviedo , 33011 Asturias , Spain
- Department of Microbiology and Biochemistry of Dairy Products , Instituto de Productos Lácteos de Asturias-Consejo Superior de Investigaciones Científicas (IPLA-CSIC) , Paseo Río Linares s/n Villaviciosa , 33300 Asturias , Spain
| | - Sonia González
- Department of Functional Biology , University of Oviedo , C/Julián Clavería s/n Oviedo , 33006 Asturias , Spain
- Group Diet, Microbiota and Health , Instituto de Investigación Sanitaria del Principado de Asturias (ISPA) , Avda. Roma s/n Oviedo , 33011 Asturias , Spain
| |
Collapse
|
37
|
Dietary Polyphenols and Periodontitis-A Mini-Review of Literature. Molecules 2018; 23:molecules23071786. [PMID: 30036945 PMCID: PMC6099717 DOI: 10.3390/molecules23071786] [Citation(s) in RCA: 35] [Impact Index Per Article: 5.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/10/2018] [Revised: 07/14/2018] [Accepted: 07/18/2018] [Indexed: 01/18/2023] Open
Abstract
Periodontitis, which is a chronic infection and disease of the periodontium, is a significant global health burden and is linked to other chronic health conditions such as diabetes and cardiovascular diseases. Dietary polyphenols present in a wide variety of plant-based foods, herbs, and botanicals have been shown to exert antimicrobial, anti-inflammatory, and reduced osteoclast and alveolar bone loss activities in animal models of periodontitis. Polyphenol-containing beverages and foods especially green tea and its active catechin epigallocatechin-3-gallate, cranberries, pomegranates, and fruit and vegetable extracts have reported bacteriostatic/bactericidal activity against microbial species such as P. gingivalis and shown total bacterial burden in clinical studies. These polyphenols also exhibit anti-inflammatory and antioxidant effects, which have the potential to impact various biological mechanisms for reducing the initiation and progression of periodontitis. The main objective of this mini-review is to focus on the mechanisms of action of dietary polyphenols in improving the pathophysiology underlying chronic inflammatory diseases like periodontitis based on pre-clinical and clinical models.
Collapse
|